William Tamborlane, MD

• Amy Steffen
• Ania Jastreboff
• Anisha Patel
• Anne Camp
• Barry Goldberg
• Catherine Yeckel
• Clifford Bogue
• Craig Summers
• Cynthia Brandt
• Dena Springer
• Douglas Rothman
• Elizabeth Roessler
• Fangyong Li
• Forrester Lee
• Gary Cline
• Gerald I Shulman
• Graeme Mason
• James Dziura
• James Smith
• Jennifer Sherr
• John Fahey
• Judith Lichtman
• Karl Insogna
• Kate Weyman
• Kitt Petersen
• Laura Marie Nally
• Lawrence Young
• Lois S. Sadler
• Lori Carria
• Margaret Grey
• Mary Savoye
• Melissa Shaw
• Michael Canarie
• Michelle Van Name
• Naomi Driesen
• Rob Goodman
• Robert Sherwin
• Sonia Caprio
• Stephan Siebel
• Stuart Weinzimer
• Susan D. Boulware
• Sylvie Dufour
• Theodore Holford
• Thomas Carpenter
• Todd Constable
• Veronika Shabanova
• Xenophon Papademetris

Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucose; Hypoglycemia; Insulin; Pediatrics; Pancreas, Artificial

• Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels.Tamborlane WV, Hintz RL, Bergman M, Genel M, Felig P, Sherwin RS. Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. The New England Journal Of Medicine 1981, 305: 303-7. PMID: 7017416, DOI: 10.1056/NEJM198108063050602.
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitusThe Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993 Sep 30;329(14):977-86.
• Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications TrialDiabetes Control and Complications Research Group. J Pediatr. 1994 Aug;125(2):177-88.
• Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. The New England Journal Of Medicine 1986, 315: 215-9. PMID: 3523245, DOI: 10.1056/NEJM198607243150402.
• Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion.Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, Tamborlane WV. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. The New England Journal Of Medicine 1988, 318: 809-14. PMID: 3281000, DOI: 10.1056/NEJM198803313181303.
• Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus.Amiel SA, Tamborlane WV, Simonson DC, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. The New England Journal Of Medicine 1987, 316: 1376-83. PMID: 3553949, DOI: 10.1056/NEJM198705283162205.
• Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.Tamborlane WV, Sherwin RS, Genel M, Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. The New England Journal Of Medicine 1979, 300: 573-8. PMID: 763270, DOI: 10.1056/NEJM197903153001101.
• Decreased epinephrine responses to hypoglycemia during sleep.Jones TW, Porter P, Sherwin RS, Davis EA, O'Leary P, Frazer F, Byrne G, Stick S, Tamborlane WV. Decreased epinephrine responses to hypoglycemia during sleep. The New England Journal Of Medicine 1998, 338: 1657-62. PMID: 9614256, DOI: 10.1056/NEJM199806043382303.
• Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes.Sherr JL, Cengiz E, Palerm CC, Clark B, Kurtz N, Roy A, Carria L, Cantwell M, Tamborlane WV, Weinzimer SA. Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes. Diabetes Care 2013, 36: 2909-14. PMID: 23757427, PMCID: PMC3781513, DOI: 10.2337/dc13-0010.
• Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes.Sherr J, Xing D, Ruedy KJ, Beck RW, Kollman C, Buckingham B, White NH, Fox L, Tsalikian E, Weinzimer S, Arbelaez AM, Tamborlane WV. Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes. Diabetes Care 2013, 36: 1470-6. PMID: 23288858, PMCID: PMC3661789, DOI: 10.2337/dc12-1697.
• Continuous glucose monitoring and intensive treatment of type 1 diabetes.Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D. Continuous glucose monitoring and intensive treatment of type 1 diabetes. The New England Journal Of Medicine 2008, 359: 1464-76. PMID: 18779236, DOI: 10.1056/NEJMoa0805017.
• Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008, 31: 934-9. PMID: 18252903, DOI: 10.2337/dc07-1967.
• Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. The New England Journal Of Medicine 2010, 363: 311-20. PMID: 20587585, DOI: 10.1056/NEJMoa1002853.
• Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes.Weinzimer SA, Sherr JL, Cengiz E, Kim G, Ruiz JL, Carria L, Voskanyan G, Roy A, Tamborlane WV. Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes. Diabetes Care 2012, 35: 1994-9. PMID: 22815298, PMCID: PMC3447854, DOI: 10.2337/dc12-0330.
• Safety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose.Sherr JL, Palau Collazo M, Cengiz E, Michaud C, Carria L, Steffen AT, Weyman K, Zgorski M, Tichy E, Tamborlane WV, Weinzimer SA. Safety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose. Diabetes Care 2014, 37: 773-9. PMID: 24170766, PMCID: PMC3931387, DOI: 10.2337/dc13-1608.
• Obesity and the metabolic syndrome in children and adolescents.Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. The New England Journal Of Medicine 2004, 350: 2362-74. PMID: 15175438, DOI: 10.1056/NEJMoa031049.
• Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial.Savoye M, Shaw M, Dziura J, Tamborlane WV, Rose P, Guandalini C, Goldberg-Gell R, Burgert TS, Cali AM, Weiss R, Caprio S. Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA 2007, 297: 2697-704. PMID: 17595270, DOI: 10.1001/jama.297.24.2697.
• A clinical trial to maintain glycemic control in youth with type 2 diabetesTODAY Study Group., Zeitler P, Hirst K, Pyle L, Linder B, Copeland K, Arslanian S, Cuttler L, Nathan DM, Tollefsen S, Wilfley D, Kaufman F. N Engl J Med. 2012 Jun 14;366(24):2247-56. doi: 10.1056/NEJMoa1109333.
• Crisis in care: limited treatment options for type 2 diabetes in adolescents and youth.Tamborlane WV, Klingensmith G. Crisis in care: limited treatment options for type 2 diabetes in adolescents and youth. Diabetes Care 2013, 36: 1777-8. PMID: 23704679, PMCID: PMC3661850, DOI: 10.2337/dc13-0743.
• Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial.Savoye M, Caprio S, Dziura J, Camp A, Germain G, Summers C, Li F, Shaw M, Nowicka P, Kursawe R, Depourcq F, Kim G, Tamborlane WV. Reversal of early abnormalities in glucose metabolism in obese youth: results of an intensive lifestyle randomized controlled trial. Diabetes Care 2014, 37: 317-24. PMID: 24062325, PMCID: PMC3898759, DOI: 10.2337/dc13-1571.
• Influence of glucagon replacement on the hyperglycemic and hyperketonemic response to prolonged somatostatin infusion in normal man.Sherwin RS, Tamborlane W, Hendler R, Saccá L, DeFronzo RA, Felig P. Influence of glucagon replacement on the hyperglycemic and hyperketonemic response to prolonged somatostatin infusion in normal man. The Journal Of Clinical Endocrinology And Metabolism 1977, 45: 1104-7. PMID: 925134, DOI: 10.1210/jcem-45-5-1104.
• Metabolic effects of somatostatin in maturity-onset diabetes.Tamborlane WV, Sherwin RS, Hendler R, Felig P. Metabolic effects of somatostatin in maturity-onset diabetes. The New England Journal Of Medicine 1977, 297: 181-3. PMID: 876274, DOI: 10.1056/NEJM197707282970403.
• Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings.DeFronzo RA, Sherwin RS, Dillingham M, Hendler R, Tamborlane WV, Felig P. Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings. The Journal Of Clinical Investigation 1978, 61: 472-9. PMID: 621284, PMCID: PMC372558, DOI: 10.1172/JCI108958.
• Diabetogenic effects of somatostatin in maturity-onset diabetes and normal man: primacy of insulin deficiency rather than glucagon excess in the pathogenesis of diabetes.Sherwin RS, Tamborlane WV, Hendler R, Felig P. Diabetogenic effects of somatostatin in maturity-onset diabetes and normal man: primacy of insulin deficiency rather than glucagon excess in the pathogenesis of diabetes. Metabolism: Clinical And Experimental 1978, 27: 1433-6. PMID: 683012.
• Biphasic effect of somatostatin on oral glucose tolerance in maturity-onset diabetes.Tamborlane WV, Sherwin RS, Hendler R, Felig P. Biphasic effect of somatostatin on oral glucose tolerance in maturity-onset diabetes. Metabolism: Clinical And Experimental 1978, 27: 849-53. PMID: 661568.
• Normalization of the growth hormone and catecholamine response to exercise in juvenile-onset diabetic subjects treated with a portable insulin infusion pump.Tamborlane WV, Sherwin RS, Koivisto V, Hendler R, Genel M, Felig P. Normalization of the growth hormone and catecholamine response to exercise in juvenile-onset diabetic subjects treated with a portable insulin infusion pump. Diabetes 1979, 28: 785-8. PMID: 446936.
• Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump.Tamborlane WV, Sherwin RS, Genel M, Felig P. Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump. Lancet 1979, 1: 1258-61. PMID: 87725.
• Treatment of juvenile-onset diabetes by subcutaneous infusion of insulin with a portable pump.Sherwin RS, Tamborlane WV, Genel M, Felig P. Treatment of juvenile-onset diabetes by subcutaneous infusion of insulin with a portable pump. Diabetes Care 1980, 3: 301-8. PMID: 6993144.
• Mineral metabolism in diabetes mellitus: changes accompanying treatment with a portable subcutaneous insulin infusion system.Gertner JM, Tamborlane WV, Horst RL, Sherwin RS, Felig P, Genel M. Mineral metabolism in diabetes mellitus: changes accompanying treatment with a portable subcutaneous insulin infusion system. The Journal Of Clinical Endocrinology And Metabolism 1980, 50: 862-6. PMID: 6246134, DOI: 10.1210/jcem-50-5-862.
• Efficacy of the insulin pump in the home treatment of pregnant diabetics.Rudolf MC, Coustan DR, Sherwin RS, Bates SE, Felig P, Genel M, Tamborlane WV. Efficacy of the insulin pump in the home treatment of pregnant diabetics. Diabetes 1981, 30: 891-5. PMID: 7028543.
• Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy.Tamborlane WV, Puklin JE, Bergman M, Verdonk C, Rudolf MC, Felig P, Genel M, Sherwin R. Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care 1982, 5 Suppl 1: 58-64. PMID: 7188047.
• Effect of intensive insulin treatment on linear growth in the young diabetic patient.Rudolf MC, Sherwin RS, Markowitz R, Bates SE, Genel M, Hochstadt J, Tamborlane WV. Effect of intensive insulin treatment on linear growth in the young diabetic patient. The Journal Of Pediatrics 1982, 101: 333-9. PMID: 7050326.
• Influence of long-term insulin infusion pump treatment of type I diabetes on diabetic retinopathy.Puklin JE, Tamborlane WV, Felig P, Genel M, Sherwin RS. Influence of long-term insulin infusion pump treatment of type I diabetes on diabetic retinopathy. Ophthalmology 1982, 89: 735-47. PMID: 6750494.
• Effect of growth hormone on oral glucose tolerance and circulating metabolic fuels in man.Sherwin RS, Schulman GA, Hendler R, Walesky M, Belous A, Tamborlane W. Effect of growth hormone on oral glucose tolerance and circulating metabolic fuels in man. Diabetologia 1983, 24: 155-61. PMID: 6341144.
• Diabetes control and complications: new strategies and insights.Tamborlane WV, Sherwin RS. Diabetes control and complications: new strategies and insights. The Journal Of Pediatrics 1983, 102: 805-13. PMID: 6343570.
• Pituitary response to growth hormone-releasing factor in diabetes. Failure of glucose-mediated suppression.Press M, Tamborlane WV, Thorner MO, Vale W, Rivier J, Gertner JM, Sherwin RS. Pituitary response to growth hormone-releasing factor in diabetes. Failure of glucose-mediated suppression. Diabetes 1984, 33: 804-6. PMID: 6430738.
• Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes.Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM, Tamborlane WV. Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes. Diabetes 1984, 33: 1175-9. PMID: 6389234.
• Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes.Press M, Tamborlane WV, Sherwin RS. Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. The New England Journal Of Medicine 1984, 310: 810-5. PMID: 6700669, DOI: 10.1056/NEJM198403293101302.
• Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes.Simonson DC, Tamborlane WV, DeFronzo RA, Sherwin RS. Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. Annals Of Internal Medicine 1985, 103: 184-90. PMID: 3893253.
• Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The pump life. Patient responses and clinical and technological problems.Pickup JC, Sherwin RS, Tamborlane WV, Rizza RA, Service FJ. Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. The pump life. Patient responses and clinical and technological problems. Diabetes 1985, 34 Suppl 3: 37-41. PMID: 3894127.
• Improved insulin sensitivity in patients with type I diabetes mellitus after CSII.Simonson DC, Tamborlane WV, Sherwin RS, Smith JD, DeFronzo RA. Improved insulin sensitivity in patients with type I diabetes mellitus after CSII. Diabetes 1985, 34 Suppl 3: 80-6. PMID: 3894130.
• A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies.Coustan DR, Reece EA, Sherwin RS, Rudolf MC, Bates SE, Sockin SM, Holford T, Tamborlane WV. A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. JAMA 1986, 255: 631-6. PMID: 3511311.
• Effect of insulin on growth hormone-induced metabolic derangements in diabetes.Press M, Tamborlane WV, Sherwin RS. Effect of insulin on growth hormone-induced metabolic derangements in diabetes. Metabolism: Clinical And Experimental 1986, 35: 956-9. PMID: 3531761.
• Lessons from glucose monitoring at night.Sherwin RS, Tamborlane WV, Ahern J. Lessons from glucose monitoring at night. Diabetes Care 1987, 10: 249-51. PMID: 3582084.
• Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children.Amiel SA, Simonson DC, Sherwin RS, Lauritano AA, Tamborlane WV. Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children. The Journal Of Pediatrics 1987, 110: 832-7. PMID: 3585599.
• Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans.Amiel SA, Simonson DC, Tamborlane WV, DeFronzo RA, Sherwin RS. Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans. Diabetes 1987, 36: 518-22. PMID: 3817305.
• Relationship between changes in glucose production and gluconeogenesis during mild hypoglycemia in humans.Caprio S, Saccà L, Tamborlane WV, Sherwin RS. Relationship between changes in glucose production and gluconeogenesis during mild hypoglycemia in humans. Metabolism: Clinical And Experimental 1988, 37: 707-10. PMID: 3043143.
• Hypoglycemia and glucose counterregulation in normal and insulin-dependent diabetic subjects.Amiel SA, Tamborlane WV, Saccà L, Sherwin RS. Hypoglycemia and glucose counterregulation in normal and insulin-dependent diabetic subjects. Diabetes/metabolism Reviews 1988, 4: 71-89. PMID: 3278875.
• Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988, 37: 901-7. PMID: 3290007.
• Effect of short-term somatostatin and long-term triiodothyronine administration in a child with nontumorous inappropriate thyrotropin secretion.Isales CM, Tamborlane W, Gertner JM, Genel M, Insogna KL. Effect of short-term somatostatin and long-term triiodothyronine administration in a child with nontumorous inappropriate thyrotropin secretion. The Journal Of Pediatrics 1988, 112: 51-5. PMID: 2891806.
• Oxidative fuel metabolism during mild hypoglycemia: critical role of free fatty acids.Caprio S, Gelfand RA, Tamborlane WV, Sherwin RS. Oxidative fuel metabolism during mild hypoglycemia: critical role of free fatty acids. The American Journal Of Physiology 1989, 256: E413-9. PMID: 2646946, DOI: 10.1152/ajpendo.1989.256.3.E413.
• Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity.Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, Sherwin RS, Tamborlane WV. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. The Journal Of Pediatrics 1989, 114: 963-7. PMID: 2524556.
• Defective free-fatty acid and oxidative glucose metabolism in IDDM during hypoglycemia. Influence of glycemic control.Caprio S, Amiel S, Tamborlane WV, Gelfand RA, Sherwin RS. Defective free-fatty acid and oxidative glucose metabolism in IDDM during hypoglycemia. Influence of glycemic control. Diabetes 1990, 39: 134-41. PMID: 2227120.
• Mild hypoglycemia and impairment of brain stem and cortical evoked potentials in healthy subjects.Jones TW, McCarthy G, Tamborlane WV, Caprio S, Roessler E, Kraemer D, Starick-Zych K, Allison T, Boulware SD, Sherwin RS. Mild hypoglycemia and impairment of brain stem and cortical evoked potentials in healthy subjects. Diabetes 1990, 39: 1550-5. PMID: 2245879.
• Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism.Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. The Journal Of Clinical Endocrinology And Metabolism 1991, 72: 277-82. PMID: 1991798, DOI: 10.1210/jcem-72-2-277.
• Suppression of counterregulatory hormone response to hypoglycemia by insulin per se.Diamond MP, Hallarman L, Starick-Zych K, Jones TW, Connolly-Howard M, Tamborlane WV, Sherwin RS. Suppression of counterregulatory hormone response to hypoglycemia by insulin per se. The Journal Of Clinical Endocrinology And Metabolism 1991, 72: 1388-90. PMID: 2026760, DOI: 10.1210/jcem-72-6-1388.
• Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects.Caprio S, Gerety G, Tamborlane WV, Jones T, Diamond M, Jacob R, Sherwin RS. Opiate blockade enhances hypoglycemic counterregulation in normal and insulin-dependent diabetic subjects. The American Journal Of Physiology 1991, 260: E852-8. PMID: 2058661, DOI: 10.1152/ajpendo.1991.260.6.E852.
• Does insulin species modify counterregulatory hormone response to hypoglycemia?Jones TW, Caprio S, Diamond MP, Hallarman L, Boulware SD, Sherwin RS, Tamborlane WV. Does insulin species modify counterregulatory hormone response to hypoglycemia? Diabetes Care 1991, 14: 728-31. PMID: 1954809.
• Independent effects of youth and poor diabetes control on responses to hypoglycemia in children.Jones TW, Boulware SD, Kraemer DT, Caprio S, Sherwin RS, Tamborlane WV. Independent effects of youth and poor diabetes control on responses to hypoglycemia in children. Diabetes 1991, 40: 358-63. PMID: 1999278.
• Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w rats.Jacob RJ, Sherwin RS, Bowen L, Fryburg D, Fagin KD, Tamborlane WV, Shulman GI. Metabolic effects of IGF-I and insulin in spontaneously diabetic BB/w rats. The American Journal Of Physiology 1991, 260: E262-8. PMID: 1996629, DOI: 10.1152/ajpendo.1991.260.2.E262.
• Does intensive glycemic control in diabetic pregnancies result in normalization of other metabolic fuels?Reece EA, Coustan DR, Sherwin RS, Tuck S, Bates S, O'Connor T, Tamborlane WV. Does intensive glycemic control in diabetic pregnancies result in normalization of other metabolic fuels? American Journal Of Obstetrics And Gynecology 1991, 165: 126-30. PMID: 1853889.
• Insulin resistance: an early metabolic defect of Turner's syndrome.Caprio S, Boulware S, Diamond M, Sherwin RS, Carpenter TO, Rubin K, Amiel S, Press M, Tamborlane WV. Insulin resistance: an early metabolic defect of Turner's syndrome. The Journal Of Clinical Endocrinology And Metabolism 1991, 72: 832-6. PMID: 2005209, DOI: 10.1210/jcem-72-4-832.
• Direct measurement of brain glucose concentrations in humans by 13C NMR spectroscopy.Gruetter R, Novotny EJ, Boulware SD, Rothman DL, Mason GF, Shulman GI, Shulman RG, Tamborlane WV. Direct measurement of brain glucose concentrations in humans by 13C NMR spectroscopy. Proceedings Of The National Academy Of Sciences Of The United States Of America 1992, 89: 1109-12. PMID: 1736294, PMCID: PMC48395.
• Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism.Boulware SD, Tamborlane WV, Matthews LS, Sherwin RS. Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism. The American Journal Of Physiology 1992, 262: E130-3. PMID: 1733244, DOI: 10.1152/ajpendo.1992.262.1.E130.
• Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia.Press M, Caprio S, Tamborlane WV, Bhushan R, Thorner M, Vale W, Rivier J, Sherwin RS. Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes 1992, 41: 17-21. PMID: 1727733.
• Impaired stimulation of gluconeogenesis during prolonged hypoglycemia in intensively treated insulin-dependent diabetic subjects.Caprio S, Napoli R, Saccà L, Tamborlane WV, Sherwin RS. Impaired stimulation of gluconeogenesis during prolonged hypoglycemia in intensively treated insulin-dependent diabetic subjects. The Journal Of Clinical Endocrinology And Metabolism 1992, 75: 1076-80. PMID: 1400874, DOI: 10.1210/jcem.75.4.1400874.
• Impairment of counterregulatory hormone responses to hypoglycemia in pregnant women with insulin-dependent diabetes mellitus.Diamond MP, Reece EA, Caprio S, Jones TW, Amiel S, DeGennaro N, Laudano A, Addabbo M, Sherwin RS, Tamborlane WV. Impairment of counterregulatory hormone responses to hypoglycemia in pregnant women with insulin-dependent diabetes mellitus. American Journal Of Obstetrics And Gynecology 1992, 166: 70-7. PMID: 1733221.
• Effect of growth hormone treatment on hyperinsulinemia associated with Turner syndrome.Caprio S, Boulware SD, Press M, Sherwin RS, Rubin K, Carpenter TO, Plewe G, Tamborlane WV. Effect of growth hormone treatment on hyperinsulinemia associated with Turner syndrome. The Journal Of Pediatrics 1992, 120: 238-43. PMID: 1735819, DOI: 10.1016/s0022-3476(05)80434-2.
• Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.Kerr D, Tamborlane WV, Rife F, Sherwin RS. Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin. The Journal Of Clinical Investigation 1993, 91: 141-7. PMID: 8423214, PMCID: PMC330007, DOI: 10.1172/JCI116163.
• Effect of caffeine on the recognition of and responses to hypoglycemia in humans.Kerr D, Sherwin RS, Pavalkis F, Fayad PB, Sikorski L, Rife F, Tamborlane WV, During MJ. Effect of caffeine on the recognition of and responses to hypoglycemia in humans. Annals Of Internal Medicine 1993, 119: 799-804. PMID: 8379601.
• Loss of potentiating effect of hypoglycemia on the glucagon response to hyperaminoacidemia in IDDM.Caprio S, Tamborlane WV, Zych K, Gerow K, Sherwin RS. Loss of potentiating effect of hypoglycemia on the glucagon response to hyperaminoacidemia in IDDM. Diabetes 1993, 42: 550-5. PMID: 8454105.
• Influence of counterregulatory hormones, independently of hypoglycaemia, on cognitive function, warning symptoms and glucose kinetics.Kerr D, Diamond MP, Tamborlane WV, Kerr S, Sherwin RS. Influence of counterregulatory hormones, independently of hypoglycaemia, on cognitive function, warning symptoms and glucose kinetics. Clinical Science (London, England : 1979) 1993, 85: 197-202. PMID: 8403788.
• Correction of hyperinsulinemia by glyburide treatment in nondiabetic patients with thalassemia major.Jones TW, Boulware SD, Caprio S, Merkel P, Amiel SA, Pearson HA, Sherwin RS, Tamborlane WV. Correction of hyperinsulinemia by glyburide treatment in nondiabetic patients with thalassemia major. Pediatric Research 1993, 33: 497-500. PMID: 8511023, DOI: 10.1203/00006450-199305000-00015.
• Gender influences counterregulatory hormone responses to hypoglycemia.Diamond MP, Jones T, Caprio S, Hallarman L, Diamond MC, Addabbo M, Tamborlane WV, Sherwin RS. Gender influences counterregulatory hormone responses to hypoglycemia. Metabolism: Clinical And Experimental 1993, 42: 1568-72. PMID: 8246771.
• Metabolic effects of rhIGF-1 in normal human subjects.Rennert NJ, Boulware SD, Kerr D, Caprio S, Tamborlane WV, Sherwin RS. Metabolic effects of rhIGF-1 in normal human subjects. Advances In Experimental Medicine And Biology 1993, 343: 311-8. PMID: 8184741.
• Non-invasive measurements of the cerebral steady-state glucose concentration and transport in humans by 13C nuclear magnetic resonance.Gruetter R, Novotny EJ, Boulware SD, Rothman DL, Mason GF, Shulman GI, Tamborlane WV, Shulman RG. Non-invasive measurements of the cerebral steady-state glucose concentration and transport in humans by 13C nuclear magnetic resonance. Advances In Experimental Medicine And Biology 1993, 331: 35-40. PMID: 8333347.
• Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.Boulware SD, Tamborlane WV, Rennert NJ, Gesundheit N, Sherwin RS. Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults. The Journal Of Clinical Investigation 1994, 93: 1131-9. PMID: 8132753, PMCID: PMC294058, DOI: 10.1172/JCI117065.
• Effects of puberty and diabetes on metabolism of insulin-sensitive fuels.Caprio S, Cline G, Boulware S, Permanente C, Shulman GI, Sherwin RS, Tamborlane WV. Effects of puberty and diabetes on metabolism of insulin-sensitive fuels. The American Journal Of Physiology 1994, 266: E885-91. PMID: 8023918, DOI: 10.1152/ajpendo.1994.266.6.E885.
• Central adiposity and its metabolic correlates in obese adolescent girls.Caprio S, Hyman LD, Limb C, McCarthy S, Lange R, Sherwin RS, Shulman G, Tamborlane WV. Central adiposity and its metabolic correlates in obese adolescent girls. The American Journal Of Physiology 1995, 269: E118-26. PMID: 7631766, DOI: 10.1152/ajpendo.1995.269.1.E118.
• Enhanced adrenomedullary response and increased susceptibility to neuroglycopenia: mechanisms underlying the adverse effects of sugar ingestion in healthy children.Jones TW, Borg WP, Boulware SD, McCarthy G, Sherwin RS, Tamborlane WV. Enhanced adrenomedullary response and increased susceptibility to neuroglycopenia: mechanisms underlying the adverse effects of sugar ingestion in healthy children. The Journal Of Pediatrics 1995, 126: 171-7. PMID: 7844661.
• Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadricep muscle and adipose tissue. Evidence for significant lipolysis in skeletal muscle.Maggs DG, Jacob R, Rife F, Lange R, Leone P, During MJ, Tamborlane WV, Sherwin RS. Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadricep muscle and adipose tissue. Evidence for significant lipolysis in skeletal muscle. The Journal Of Clinical Investigation 1995, 96: 370-7. PMID: 7615807, PMCID: PMC185209, DOI: 10.1172/JCI118043.
• Fetal Doppler and behavioral responses during hypoglycemia induced with the insulin clamp technique in pregnant diabetic women.Reece EA, Hagay Z, Roberts AB, DeGennaro N, Homko CJ, Connolly-Diamond M, Sherwin R, Tamborlane WV, Diamond MP. Fetal Doppler and behavioral responses during hypoglycemia induced with the insulin clamp technique in pregnant diabetic women. American Journal Of Obstetrics And Gynecology 1995, 172: 151-5. PMID: 7847527.
• Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations.Caprio S, Tamborlane WV, Silver D, Robinson C, Leibel R, McCarthy S, Grozman A, Belous A, Maggs D, Sherwin RS. Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations. The American Journal Of Physiology 1996, 271: E626-30. PMID: 8843759, DOI: 10.1152/ajpendo.1996.271.3.E626.
• Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children.Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children. Diabetologia 1996, 39: 1489-97. PMID: 8960831.
• Acute incretin response to oral glucose is associated with stimulation of gastric inhibitory polypeptide, not glucagon-like peptide in young subjects.Limb C, Tamborlane WV, Sherwin RS, Pederson R, Caprio S. Acute incretin response to oral glucose is associated with stimulation of gastric inhibitory polypeptide, not glucagon-like peptide in young subjects. Pediatric Research 1997, 41: 364-7. PMID: 9078536, DOI: 10.1203/00006450-199703000-00010.
• Counterregulation in peripheral tissues: effect of systemic hypoglycemia on levels of substrates and catecholamines in human skeletal muscle and adipose tissue.Maggs DG, Jacob R, Rife F, Caprio S, Tamborlane WV, Sherwin RS. Counterregulation in peripheral tissues: effect of systemic hypoglycemia on levels of substrates and catecholamines in human skeletal muscle and adipose tissue. Diabetes 1997, 46: 70-6. PMID: 8971084.
• Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats.Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. The Journal Of Clinical Investigation 1997, 99: 361-5. PMID: 9006005, PMCID: PMC507804, DOI: 10.1172/JCI119165.
• The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity.Attia N, Tamborlane WV, Heptulla R, Maggs D, Grozman A, Sherwin RS, Caprio S. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. The Journal Of Clinical Endocrinology And Metabolism 1998, 83: 1467-71. PMID: 9589640, DOI: 10.1210/jcem.83.5.4827.
• Effect of insulin on glycerol production in obese adolescents.Robinson C, Tamborlane WV, Maggs DG, Enoksson S, Sherwin RS, Silver D, Shulman GI, Caprio S. Effect of insulin on glycerol production in obese adolescents. The American Journal Of Physiology 1998, 274: E737-43. PMID: 9575836.
• Short-term effects of coping skills training as adjunct to intensive therapy in adolescents.Grey M, Boland EA, Davidson M, Yu C, Sullivan-Bolyai S, Tamborlane WV. Short-term effects of coping skills training as adjunct to intensive therapy in adolescents. Diabetes Care 1998, 21: 902-8. PMID: 9614605, DOI: 10.2337/diacare.21.6.902.
• Personal and family factors associated with quality of life in adolescents with diabetes.Grey M, Boland EA, Yu C, Sullivan-Bolyai S, Tamborlane WV. Personal and family factors associated with quality of life in adolescents with diabetes. Diabetes Care 1998, 21: 909-14. PMID: 9614606, DOI: 10.2337/diacare.21.6.909.
• Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes.Attia N, Caprio S, Jones TW, Heptulla R, Holcombe J, Silver D, Sherwin RS, Tamborlane WV. Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes. The Journal Of Clinical Endocrinology And Metabolism 1999, 84: 2324-8. PMID: 10404797, DOI: 10.1210/jcem.84.7.5861.
• Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats.Borg MA, Borg WP, Tamborlane WV, Brines ML, Shulman GI, Sherwin RS. Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxy-glucose perfusion of the ventromedial hypothalamus in rats. Diabetes 1999, 48: 584-7. PMID: 10078560.
• Metabolic impact of obesity in childhood.Caprio S, Tamborlane WV. Metabolic impact of obesity in childhood. Endocrinology And Metabolism Clinics Of North America 1999, 28: 731-47. PMID: 10609117, DOI: 10.1016/s0889-8529(05)70099-2.
• Changes in body composition after a 12-wk aerobic exercise program in obese boys.DeStefano RA, Caprio S, Fahey JT, Tamborlane WV, Goldberg B. Changes in body composition after a 12-wk aerobic exercise program in obese boys. Pediatric Diabetes 2000, 1: 61-5. PMID: 15016230, DOI: 10.1034/j.1399-5448.2000.010202.x.
• Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life.Grey M, Boland EA, Davidson M, Li J, Tamborlane WV. Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. The Journal Of Pediatrics 2000, 137: 107-13. PMID: 10891831, DOI: 10.1067/mpd.2000.106568.
• Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity.Heptulla RA, Tamborlane WV, Cavaghan M, Bronson M, Limb C, Ma YZ, Sherwin RS, Caprio S. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity. Pediatric Research 2000, 47: 628-33. PMID: 10813588.
• Impaired in vivo stimulation of lipolysis in adipose tissue by selective beta2-adrenergic agonist in obese adolescent girls.Enoksson S, Talbot M, Rife F, Tamborlane WV, Sherwin RS, Caprio S. Impaired in vivo stimulation of lipolysis in adipose tissue by selective beta2-adrenergic agonist in obese adolescent girls. Diabetes 2000, 49: 2149-53. PMID: 11118019.
• Cardiac responses to insulin-induced hypoglycemia in nondiabetic and intensively treated type 1 diabetic patients.Russell RR, Chyun D, Song S, Sherwin RS, Tamborlane WV, Lee FA, Pfeifer MA, Rife F, Wackers FJ, Young LH. Cardiac responses to insulin-induced hypoglycemia in nondiabetic and intensively treated type 1 diabetic patients. American Journal Of Physiology. Endocrinology And Metabolism 2001, 281: E1029-36. PMID: 11595660, DOI: 10.1152/ajpendo.2001.281.5.E1029.
• Oral glucose augments the counterregulatory hormone response during insulin-induced hypoglycemia in humans.Heptulla RA, Tamborlane WV, Ma TY, Rife F, Sherwin RS. Oral glucose augments the counterregulatory hormone response during insulin-induced hypoglycemia in humans. The Journal Of Clinical Endocrinology And Metabolism 2001, 86: 645-8. PMID: 11158023, DOI: 10.1210/jcem.86.2.7198.
• Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes.Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001, 24: 1858-62. PMID: 11679447.
• Clinical and psychosocial factors associated with achievement of treatment goals in adolescents with diabetes mellitus.Grey M, Davidson M, Boland EA, Tamborlane WV. Clinical and psychosocial factors associated with achievement of treatment goals in adolescents with diabetes mellitus. The Journal Of Adolescent Health : Official Publication Of The Society For Adolescent Medicine 2001, 28: 377-85. PMID: 11336867, DOI: 10.1016/s1054-139x(00)00211-1.
• Prevalence of impaired glucose tolerance among children and adolescents with marked obesity.Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. The New England Journal Of Medicine 2002, 346: 802-10. PMID: 11893791, DOI: 10.1056/NEJMoa012578.
• Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia?Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, Tamborlane WV. Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care 2002, 25: 889-93. PMID: 11978686, DOI: 10.2337/diacare.25.5.889.
• Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes.Bode BW, Tamborlane WV, Davidson PC. Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes. Postgraduate Medicine 2002, 111: 69-77; quiz 27. PMID: 12040864, DOI: 10.3810/pgm.2002.05.1200.
• Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups.Ahern JA, Boland EA, Doane R, Ahern JJ, Rose P, Vincent M, Tamborlane WV. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatric Diabetes 2002, 3: 10-5. PMID: 15016169, DOI: 10.1034/j.1399-5448.2002.30103.x.
• Mothers' experiences raising young children with type 1 diabetes.Sullivan-Bolyai S, Deatrick J, Gruppuso P, Tamborlane W, Grey M. Mothers' experiences raising young children with type 1 diabetes. Journal For Specialists In Pediatric Nursing : JSPN 2002, 7: 93-103. PMID: 12236249, DOI: 10.1111/j.1744-6155.2002.tb00158.x.
• Depression in type 1 diabetes in children: natural history and correlates.Grey M, Whittemore R, Tamborlane W. Depression in type 1 diabetes in children: natural history and correlates. Journal Of Psychosomatic Research 2002, 53: 907-11. PMID: 12377302, DOI: 10.1016/s0022-3999(02)00312-4.
• Insulin pump therapy in children and adolescents.Tamborlane WV, Boland EA, Ahern JH. Insulin pump therapy in children and adolescents. Diabetes, Nutrition & Metabolism 2002, 15: 422-5. PMID: 12678461.
• Importance of plasma leptin in predicting future weight gain in obese children: a two-and-a-half-year longitudinal study.Savoye M, Dziura J, Castle J, DiPietro L, Tamborlane WV, Caprio S. Importance of plasma leptin in predicting future weight gain in obese children: a two-and-a-half-year longitudinal study. International Journal Of Obesity And Related Metabolic Disorders : Journal Of The International Association For The Study Of Obesity 2002, 26: 942-6. PMID: 12080447, DOI: 10.1038/sj.ijo.0802018.
• Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia.Enoksson S, Caprio SK, Rife F, Shulman GI, Tamborlane WV, Sherwin RS. Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia. The Journal Of Clinical Endocrinology And Metabolism 2003, 88: 1503-11. PMID: 12679430, DOI: 10.1210/jc.2002-021013.
• Analysis of continuous glucose monitoring data from non-diabetic and diabetic children: a tale of two algorithms.Weinzimer SA, DeLucia MC, Boland EA, Steffen A, Tamborlane WV. Analysis of continuous glucose monitoring data from non-diabetic and diabetic children: a tale of two algorithms. Diabetes Technology & Therapeutics 2003, 5: 375-80. PMID: 12828820, DOI: 10.1089/152091503765691866.
• The influence of insulin on circulating ghrelin.Flanagan DE, Evans ML, Monsod TP, Rife F, Heptulla RA, Tamborlane WV, Sherwin RS. The influence of insulin on circulating ghrelin. American Journal Of Physiology. Endocrinology And Metabolism 2003, 284: E313-6. PMID: 12531744, DOI: 10.1152/ajpendo.00569.2001.
• Quality of life in school-aged children with type 1 diabetes on intensive treatment and their parents.Whittemore R, Urban AD, Tamborlane WV, Grey M. Quality of life in school-aged children with type 1 diabetes on intensive treatment and their parents. The Diabetes Educator 2003, 29: 847-54. PMID: 14603873, DOI: 10.1177/014572170302900514.
• In situ evidence that peripheral insulin resistance in adolescents with poorly controlled type 1 diabetes is associated with impaired suppression of lipolysis: a microdialysis study.Heptulla RA, Stewart A, Enocksson S, Rife F, Ma TY, Sherwin RS, Tamborlane WV, Caprio S. In situ evidence that peripheral insulin resistance in adolescents with poorly controlled type 1 diabetes is associated with impaired suppression of lipolysis: a microdialysis study. Pediatric Research 2003, 53: 830-5. PMID: 12702748, DOI: 10.1203/01.PDR.0000059552.08913.B7.
• Local lactate perfusion of the ventromedial hypothalamus suppresses hypoglycemic counterregulation.Borg MA, Tamborlane WV, Shulman GI, Sherwin RS. Local lactate perfusion of the ventromedial hypothalamus suppresses hypoglycemic counterregulation. Diabetes 2003, 52: 663-6. PMID: 12606506, DOI: 10.2337/diabetes.52.3.663.
• Insulin pump therapy in childhood diabetes mellitus: guidelines for use.Tamborlane WV, Fredrickson LP, Ahern JH. Insulin pump therapy in childhood diabetes mellitus: guidelines for use. Treatments In Endocrinology 2003, 2: 11-21. PMID: 15871551, DOI: 10.2165/00024677-200302010-00002.
• Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning.Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, Boselli L, Barbetta G, Allen K, Rife F, Savoye M, Dziura J, Sherwin R, Shulman GI, Caprio S. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet 2003, 362: 951-7. PMID: 14511928, PMCID: PMC2995523, DOI: 10.1016/S0140-6736(03)14364-4.
• Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents.Yeckel CW, Weiss R, Dziura J, Taksali SE, Dufour S, Burgert TS, Tamborlane WV, Caprio S. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. The Journal Of Clinical Endocrinology And Metabolism 2004, 89: 1096-101. PMID: 15001593, DOI: 10.1210/jc.2003-031503.
• A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004, 27: 1554-8. PMID: 15220227, DOI: 10.2337/diacare.27.7.1554.
• Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study.Mauras N, Beck RW, Ruedy KJ, Kollman C, Tamborlane WV, Chase HP, Buckingham BA, Tsalikian E, Weinzimer S, Booth AD, Xing D. Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. The Journal Of Pediatrics 2004, 144: 770-5. PMID: 15192625, PMCID: PMC2248702, DOI: 10.1016/j.jpeds.2004.03.042.
• Parents' reflections on managing their children's diabetes with insulin pumps.Sullivan-Bolyai S, Knafl K, Tamborlane W, Grey M. Parents' reflections on managing their children's diabetes with insulin pumps. Journal Of Nursing Scholarship : An Official Publication Of Sigma Theta Tau International Honor Society Of Nursing / Sigma Theta Tau 2004, 36: 316-23. PMID: 15636411, DOI: 10.1111/j.1547-5069.2004.04058.x.
• Helping other mothers effectively work at raising young children with type 1 diabetes.Sullivan-Bolyai S, Grey M, Deatrick J, Gruppuso P, Giraitis P, Tamborlane W. Helping other mothers effectively work at raising young children with type 1 diabetes. The Diabetes Educator 2004, 30: 476-84. PMID: 15208845, DOI: 10.1177/014572170403000319.
• Continuous glucose monitoring in type 1 diabetes.Weinzimer SA, Tamborlane WV, Chase HP, Garg SK. Continuous glucose monitoring in type 1 diabetes. Current Diabetes Reports 2004, 4: 95-100. PMID: 15035968, DOI: 10.1007/s11892-004-0063-z.
• Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report.Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT, Tamborlane WV. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004, 114: 1601-5. PMID: 15574621, DOI: 10.1542/peds.2004-0092.
• GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children.Tsalikian E, Kollman C, Mauras N, Weinzimer S, Buckingham B, Xing D, Beck R, Ruedy K, Tamborlane W, Fiallo-Scharer R. GlucoWatch G2 Biographer alarm reliability during hypoglycemia in children. Diabetes Technology & Therapeutics 2004, 6: 559-66. PMID: 15628809, PMCID: PMC2302787, DOI: 10.1089/dia.2004.6.559.
• Rediscovery of insulin pump treatment of childhood type 1 diabetes.Weinzimer SA, Doyle EA, Steffen AT, Sikes KA, Tamborlane WV. Rediscovery of insulin pump treatment of childhood type 1 diabetes. Minerva Medica 2004, 95: 85-92. PMID: 15272243.
• Predictors of changes in glucose tolerance status in obese youth.Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 2005, 28: 902-9. PMID: 15793193, DOI: 10.2337/diacare.28.4.902.
• Single- and multiple-dose pharmacokinetics of pioglitazone in adolescents with type 2 diabetes.Christensen ML, Meibohm B, Capparelli EV, Velasquez-Mieyer P, Burghen GA, Tamborlane WV. Single- and multiple-dose pharmacokinetics of pioglitazone in adolescents with type 2 diabetes. Journal Of Clinical Pharmacology 2005, 45: 1137-44. PMID: 16172178, DOI: 10.1177/0091270005279578.
• Case study: contrasting challenges of insulin pump therapy in a toddler and adolescent with type 1 diabetes.Doyle Boland EA, Steffen AT, Tamborlane WV. Case study: contrasting challenges of insulin pump therapy in a toddler and adolescent with type 1 diabetes. The Diabetes Educator 2005, 31: 584-90. PMID: 16100334, DOI: 10.1177/0145721705278888.
• Disease management in the young diabetic patient: glucose monitoring, coping skills, and treatment strategies.Weinzimer SA, Doyle EA, Tamborlane WV. Disease management in the young diabetic patient: glucose monitoring, coping skills, and treatment strategies. Clinical Pediatrics 2005, 44: 393-403. PMID: 15965545, DOI: 10.1177/000992280504400503.
• Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus.Tsalikian E, Mauras N, Beck RW, Tamborlane WV, Janz KF, Chase HP, Wysocki T, Weinzimer SA, Buckingham BA, Kollman C, Xing D, Ruedy KJ. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. The Journal Of Pediatrics 2005, 147: 528-34. PMID: 16227041, PMCID: PMC2258153, DOI: 10.1016/j.jpeds.2005.04.065.
• Limitations of statistical measures of error in assessing the accuracy of continuous glucose sensors.Kollman C, Wilson DM, Wysocki T, Tamborlane WV, Beck RW. Limitations of statistical measures of error in assessing the accuracy of continuous glucose sensors. Diabetes Technology & Therapeutics 2005, 7: 665-72; discussion 673-4. PMID: 16241865, PMCID: PMC1805466, DOI: 10.1089/dia.2005.7.665.
• The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance.Yeckel CW, Taksali SE, Dziura J, Weiss R, Burgert TS, Sherwin RS, Tamborlane WV, Caprio S. The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance. The Journal Of Clinical Endocrinology And Metabolism 2005, 90: 747-54. PMID: 15522932, DOI: 10.1210/jc.2004-1258.
• Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study.Weinzimer SA, Beck RW, Chase HP, Fox LA, Buckingham BA, Tamborlane WV, Kollman C, Coffey J, Xing D, Ruedy KJ. Accuracy of newer-generation home blood glucose meters in a Diabetes Research in Children Network (DirecNet) inpatient exercise study. Diabetes Technology & Therapeutics 2005, 7: 675-80; discussion 681-3. PMID: 16241867, PMCID: PMC1351386, DOI: 10.1089/dia.2005.7.675.
• Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study.Tansey MJ, Beck RW, Buckingham BA, Mauras N, Fiallo-Scharer R, Xing D, Killman C, Tamborlane WV, Ruedy KJ. Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. Diabetes Technology & Therapeutics 2005, 7: 109-14. PMID: 15738708, PMCID: PMC2254760, DOI: 10.1089/dia.2005.7.109.
• A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes.Chase HP, Beck R, Tamborlane W, Buckingham B, Mauras N, Tsalikian E, Wysocki T, Weinzimer S, Kollman C, Ruedy K, Xing D. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005, 28: 1101-6. PMID: 15855573, DOI: 10.2337/diacare.28.5.1101.
• Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study.Tamborlane WV, Kollman C, Steffes MW, Ruedy KJ, Dongyuan X, Beck RW, Chase P, Fox LA, Wilson DM, Tsalikian E. Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatric Diabetes 2005, 6: 13-6. PMID: 15787896, DOI: 10.1111/j.1399-543X.2005.00088.x.
• The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning.Weiss R, Taksali SE, Dufour S, Yeckel CW, Papademetris X, Cline G, Tamborlane WV, Dziura J, Shulman GI, Caprio S. The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning. The Journal Of Clinical Endocrinology And Metabolism 2005, 90: 3731-7. PMID: 15797955, DOI: 10.1210/jc.2004-2305.
• Beta-cell function across the spectrum of glucose tolerance in obese youth.Weiss R, Caprio S, Trombetta M, Taksali SE, Tamborlane WV, Bonadonna R. Beta-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 2005, 54: 1735-43. PMID: 15919795, DOI: 10.2337/diabetes.54.6.1735.
• Insulin pump treatment of childhood type 1 diabetes.Weinzimer SA, Sikes KA, Steffen AT, Tamborlane WV. Insulin pump treatment of childhood type 1 diabetes. Pediatric Clinics Of North America 2005, 52: 1677-88. PMID: 16301088, DOI: 10.1016/j.pcl.2005.07.004.
• Diabetes in overweight pediatric patients.Tamborlane WV. Diabetes in overweight pediatric patients. Clinical Cornerstone 2005, 7 Suppl 3: S25-9. PMID: 16545735, DOI: 10.1016/s1098-3597(05)80086-9.
• Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat.Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M, Seyal AA, Caprio S. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. The Journal Of Clinical Endocrinology And Metabolism 2006, 91: 4287-94. PMID: 16912127, DOI: 10.1210/jc.2006-1010.
• Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment.Springer D, Dziura J, Tamborlane WV, Steffen AT, Ahern JH, Vincent M, Weinzimer SA. Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment. The Journal Of Pediatrics 2006, 149: 227-32. PMID: 16887440, DOI: 10.1016/j.jpeds.2006.03.052.
• Evaluation of factors affecting CGMS calibration.Buckingham BA, Kollman C, Beck R, Kalajian A, Fiallo-Scharer R, Tansey MJ, Fox LA, Wilson DM, Weinzimer SA, Ruedy KJ, Tamborlane WV. Evaluation of factors affecting CGMS calibration. Diabetes Technology & Therapeutics 2006, 8: 318-25. PMID: 16800753, PMCID: PMC1483845, DOI: 10.1089/dia.2006.8.318.
• Insulin pumps in pediatrics: we have the technology. We have the evidence. Why are still so few kids using it?Danne T, Tamborlane WV. Insulin pumps in pediatrics: we have the technology. We have the evidence. Why are still so few kids using it? Pediatric Diabetes 2006, 7 Suppl 4: 2-3. PMID: 16774610, DOI: 10.1111/j.1399-543X.2006.00165.x.
• Fulfilling the promise of insulin pump therapy in childhood diabetes.Tamborlane WV. Fulfilling the promise of insulin pump therapy in childhood diabetes. Pediatric Diabetes 2006, 7 Suppl 4: 4-10. PMID: 16774611, DOI: 10.1111/j.1399-543X.2006.00171.x.
• Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin.Tsalikian E, Kollman C, Tamborlane WB, Beck RW, Fiallo-Scharer R, Fox L, Janz KF, Ruedy KJ, Wilson D, Xing D, Weinzimer SA. Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care 2006, 29: 2200-4. PMID: 17003293, PMCID: PMC1584283, DOI: 10.2337/dc06-0495.
• The renaissance of insulin pump treatment in childhood type 1 diabetes.Tamborlane WV, Swan K, Sikes KA, Steffen AT, Weinzimer SA. The renaissance of insulin pump treatment in childhood type 1 diabetes. Reviews In Endocrine & Metabolic Disorders 2006, 7: 205-13. PMID: 17160722, DOI: 10.1007/s11154-006-9018-9.
• Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes.Tamborlane WV, Sikes KA, Steffen AT, Weinzimer SA. Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes. Diabetes Research And Clinical Practice 2006, 74 Suppl 2: S112-5. PMID: 17182301, DOI: 10.1016/S0168-8227(06)70011-0.
• Effects of hypoglycemia on human brain activation measured with fMRI.Anderson AW, Heptulla RA, Driesen N, Flanagan D, Goldberg PA, Jones TW, Rife F, Sarofin H, Tamborlane W, Sherwin R, Gore JC. Effects of hypoglycemia on human brain activation measured with fMRI. Magnetic Resonance Imaging 2006, 24: 693-7. PMID: 16824963, DOI: 10.1016/j.mri.2006.03.013.
• Microalbuminuria in pediatric obesity: prevalence and relation to other cardiovascular risk factors.Burgert TS, Dziura J, Yeckel C, Taksali SE, Weiss R, Tamborlane W, Caprio S. Microalbuminuria in pediatric obesity: prevalence and relation to other cardiovascular risk factors. International Journal Of Obesity (2005) 2006, 30: 273-80. PMID: 16231019, DOI: 10.1038/sj.ijo.0803136.
• The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes.Tansey MJ, Tsalikian E, Beck RW, Mauras N, Buckingham BA, Weinzimer SA, Janz KF, Kollman C, Xing D, Ruedy KJ, Steffes MW, Borland TM, Singh RJ, Tamborlane WV. The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care 2006, 29: 20-5. PMID: 16373890, PMCID: PMC2396943, DOI: 10.2337/diacare.29.1.20.
• Ethnic differences in beta cell adaptation to insulin resistance in obese children and adolescents.Weiss R, Dziura JD, Burgert TS, Taksali SE, Tamborlane WV, Caprio S. Ethnic differences in beta cell adaptation to insulin resistance in obese children and adolescents. Diabetologia 2006, 49: 571-9. PMID: 16456682, DOI: 10.1007/s00125-005-0109-z.
• Continuous glucose monitoring in children with type 1 diabetes.Buckingham B, Beck RW, Tamborlane WV, Xing D, Kollman C, Fiallo-Scharer R, Mauras N, Ruedy KJ, Tansey M, Weinzimer SA, Wysocki T. Continuous glucose monitoring in children with type 1 diabetes. The Journal Of Pediatrics 2007, 151: 388-93, 393.e1-2. PMID: 17889075, PMCID: PMC2045068, DOI: 10.1016/j.jpeds.2007.03.047.
• The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes.Wilson DM, Beck RW, Tamborlane WV, Dontchev MJ, Kollman C, Chase P, Fox LA, Ruedy KJ, Tsalikian E, Weinzimer SA. The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care 2007, 30: 59-64. PMID: 17192334, PMCID: PMC1764630, DOI: 10.2337/dc06-1407.
• Relative inaccuracy of the A1cNow in children with type 1 diabetes.Fox L, Dontchev M, Ruedy K, Beck R, Kollman C, Messer L, Coffey J, Wilson D, Doyle E, Tamborlane W, Steffes M. Relative inaccuracy of the A1cNow in children with type 1 diabetes. Diabetes Care 2007, 30: 135-7. PMID: 17192346, PMCID: PMC1978195, DOI: 10.2337/dc06-0972.
• The transition to young adulthood in youth with type 1 diabetes on intensive treatment.Insabella G, Grey M, Knafl G, Tamborlane W. The transition to young adulthood in youth with type 1 diabetes on intensive treatment. Pediatric Diabetes 2007, 8: 228-34. PMID: 17659065, DOI: 10.1111/j.1399-5448.2007.00266.x.
• Clinical outcomes and cost-effectiveness of retinopathy screening in youth with type 1 diabetes.Huo B, Steffen AT, Swan K, Sikes K, Weinzimer SA, Tamborlane WV. Clinical outcomes and cost-effectiveness of retinopathy screening in youth with type 1 diabetes. Diabetes Care 2007, 30: 362-3. PMID: 17259509, DOI: 10.2337/dc06-1824.
• Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes.Zeitler P, Epstein L, Grey M, Hirst K, Kaufman F, Tamborlane W, Wilfley D. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatric Diabetes 2007, 8: 74-87. PMID: 17448130, PMCID: PMC2752327, DOI: 10.1111/j.1399-5448.2007.00237.x.
• Triple jeopardy: nocturnal hypoglycemia after exercise in the young with diabetes.Tamborlane WV. Triple jeopardy: nocturnal hypoglycemia after exercise in the young with diabetes. The Journal Of Clinical Endocrinology And Metabolism 2007, 92: 815-6. PMID: 17341578, DOI: 10.1210/jc.2007-0016.
• Decompensated hyperglycemic hyperosmolarity without significant ketoacidosis in the adolescent and young adult population.Canarie MF, Bogue CW, Banasiak KJ, Weinzimer SA, Tamborlane WV. Decompensated hyperglycemic hyperosmolarity without significant ketoacidosis in the adolescent and young adult population. Journal Of Pediatric Endocrinology & Metabolism : JPEM 2007, 20: 1115-24. PMID: 18051930, DOI: 10.1515/jpem.2007.20.10.1115.
• Degree of obesity and glucose allostasis are major effectors of glucose tolerance dynamics in obese youth.Weiss R, Cali AM, Dziura J, Burgert TS, Tamborlane WV, Caprio S. Degree of obesity and glucose allostasis are major effectors of glucose tolerance dynamics in obese youth. Diabetes Care 2007, 30: 1845-50. PMID: 17475938, DOI: 10.2337/dc07-0325.
• Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator).Buckingham B, Xing D, Weinzimer S, Fiallo-Scharer R, Kollman C, Mauras N, Tsalikian E, Tamborlane W, Wysocki T, Ruedy K, Beck R. Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator). Pediatric Diabetes 2008, 9: 142-7. PMID: 18221427, PMCID: PMC2390770, DOI: 10.1111/j.1399-5448.2007.00301.x.
• FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group.Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wysocki T, Beck R, Tamborlane W, Ruedy K. FreeStyle navigator continuous glucose monitoring system use in children with type 1 diabetes using glargine-based multiple daily dose regimens: results of a pilot trial Diabetes Research in Children Network (DirecNet) Study Group. Diabetes Care 2008, 31: 525-7. PMID: 18096811, PMCID: PMC2365493, DOI: 10.2337/dc07-1995.
• Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus.Chase HP, Arslanian S, White NH, Tamborlane WV. Insulin glargine versus intermediate-acting insulin as the basal component of multiple daily injection regimens for adolescents with type 1 diabetes mellitus. The Journal Of Pediatrics 2008, 153: 547-53. PMID: 18589448, DOI: 10.1016/j.jpeds.2008.04.063.
• Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance.Burgert TS, Duran EJ, Goldberg-Gell R, Dziura J, Yeckel CW, Katz S, Tamborlane WV, Caprio S. Short-term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance. Pediatric Diabetes 2008, 9: 567-76. PMID: 18761646, DOI: 10.1111/j.1399-5448.2008.00434.x.
• Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes.Swan KL, Weinzimer SA, Dziura JD, Steil GM, Voskanyan GR, Steffen AT, Martin ML, Tamborlane WV. Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes. Diabetes Care 2008, 31: 44-6. PMID: 17909083, DOI: 10.2337/dc07-0737.
• Past, present, and future of insulin pump therapy: better shot at diabetes control.Sherr J, Tamborlane WV. Past, present, and future of insulin pump therapy: better shot at diabetes control. The Mount Sinai Journal Of Medicine, New York 2008, 75: 352-61. PMID: 18729180, PMCID: PMC2562271, DOI: 10.1002/msj.20055.
• Low-fat vs. high-fat bedtime snacks in children and adolescents with type 1 diabetes.Wilson D, Chase HP, Kollman C, Xing D, Caswell K, Tansey M, Fox L, Weinzimer S, Beck R, Ruedy K, Tamborlane W. Low-fat vs. high-fat bedtime snacks in children and adolescents with type 1 diabetes. Pediatric Diabetes 2008, 9: 320-5. PMID: 18768036, PMCID: PMC2593894, DOI: 10.1111/j.1399-5448.2008.00393.x.
• Sensor-augmented pump therapy in type 1 diabetes.Weinzimer SA, Tamborlane WV. Sensor-augmented pump therapy in type 1 diabetes. Current Opinion In Endocrinology, Diabetes, And Obesity 2008, 15: 118-22. PMID: 18316945, DOI: 10.1097/MED.0b013e3282f7960b.
• Blunted counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes.Tsalikian E, Tamborlane W, Xing D, Becker DM, Mauras N, Fiallo-Scharer R, Buckingham B, Weinzimer S, Steffes M, Singh R, Beck R, Ruedy K, Kollman C. Blunted counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes. Diabetes Care 2009, 32: 1954-9. PMID: 19675205, PMCID: PMC2768200, DOI: 10.2337/dc08-2298.
• Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care 2009, 32: 1947-53. PMID: 19675206, PMCID: PMC2768196, DOI: 10.2337/dc09-0889.
• Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes.Bode B, Beck RW, Xing D, Gilliam L, Hirsch I, Kollman C, Laffel L, Ruedy KJ, Tamborlane WV, Weinzimer S, Wolpert H. Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care 2009, 32: 2047-9. PMID: 19675193, PMCID: PMC2768224, DOI: 10.2337/dc09-0846.
• Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system.Cengiz E, Swan KL, Tamborlane WV, Steil GM, Steffen AT, Weinzimer SA. Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system. Diabetes Technology & Therapeutics 2009, 11: 207-10. PMID: 19344194, PMCID: PMC2842075, DOI: 10.1089/dia.2008.0102.
• Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy.Swan KL, Dziura JD, Steil GM, Voskanyan GR, Sikes KA, Steffen AT, Martin ML, Tamborlane WV, Weinzimer SA. Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care 2009, 32: 240-4. PMID: 19017777, PMCID: PMC2628686, DOI: 10.2337/dc08-0595.
• Effect of a successful intensive lifestyle program on insulin sensitivity and glucose tolerance in obese youth.Shaw M, Savoye M, Cali A, Dziura J, Tamborlane WV, Caprio S. Effect of a successful intensive lifestyle program on insulin sensitivity and glucose tolerance in obese youth. Diabetes Care 2009, 32: 45-7. PMID: 18840769, PMCID: PMC2606827, DOI: 10.2337/dc08-0808.
• Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes.White NH, Chase HP, Arslanian S, Tamborlane WV. Comparison of glycemic variability associated with insulin glargine and intermediate-acting insulin when used as the basal component of multiple daily injections for adolescents with type 1 diabetes. Diabetes Care 2009, 32: 387-93. PMID: 19106380, PMCID: PMC2646014, DOI: 10.2337/dc08-0800.
• Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.Weinzimer S, Xing D, Tansey M, Fiallo-Scharer R, Mauras N, Wysocki T, Beck R, Tamborlane W, Ruedy K. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy. Pediatric Diabetes 2009, 10: 91-6. PMID: 19175899, DOI: 10.1111/j.1399-5448.2008.00476.x.
• Continuous glucose monitoring in type 1 diabetes mellitus.Tamborlane WV, Beck RW. Continuous glucose monitoring in type 1 diabetes mellitus. Lancet 2009, 373: 1744-6. PMID: 19465217, DOI: 10.1016/S0140-6736(09)60962-4.
• A tale of two compartments: interstitial versus blood glucose monitoring.Cengiz E, Tamborlane WV. A tale of two compartments: interstitial versus blood glucose monitoring. Diabetes Technology & Therapeutics 2009, 11 Suppl 1: S11-6. PMID: 19469670, PMCID: PMC2903977, DOI: 10.1089/dia.2009.0002.
• From pumps to prevention: recent advances in the treatment of type 1 diabetes.Sherr J, Cengiz E, Tamborlane WV. From pumps to prevention: recent advances in the treatment of type 1 diabetes. Drug Discovery Today 2009, 14: 973-81. PMID: 19580883, DOI: 10.1016/j.drudis.2009.06.011.
• The effect of continuous glucose monitoring in well-controlled type 1 diabetes.Beck RW, Hirsch IB, Laffel L, Tamborlane WV, Bode BW, Buckingham B, Chase P, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Huang ES, Kollman C, Kowalski AJ, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer SA, Wilson DM, Wolpert H, Wysocki T, Xing D. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009, 32: 1378-83. PMID: 19429875, PMCID: PMC2713649, DOI: 10.2337/dc09-0108.
• Practical aspects of real-time continuous glucose monitors: the experience of the Yale Children's Diabetes Program.Ives B, Sikes K, Urban A, Stephenson K, Tamborlane WV. Practical aspects of real-time continuous glucose monitors: the experience of the Yale Children's Diabetes Program. The Diabetes Educator 2010, 36: 53-62. PMID: 19933872, PMCID: PMC2863334, DOI: 10.1177/0145721709352010.
• Early pharmacokinetic and pharmacodynamic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes.Cengiz E, Tamborlane WV, Martin-Fredericksen M, Dziura J, Weinzimer SA. Early pharmacokinetic and pharmacodynamic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes. Diabetes Care 2010, 33: 1009-12. PMID: 20150302, PMCID: PMC2858163, DOI: 10.2337/dc09-2118.
• Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents.White NH, Sun W, Cleary PA, Tamborlane WV, Danis RP, Hainsworth DP, Davis MD. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes 2010, 59: 1244-53. PMID: 20150283, PMCID: PMC2857905, DOI: 10.2337/db09-1216.
• Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring.Blevins TC, Bode BW, Garg SK, Grunberger G, Hirsch IB, Jovanovic L, Nardacci E, Orzeck EA, Roberts VL, Tamborlane WV, Rothermel C. Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocrine Practice : Official Journal Of The American College Of Endocrinology And The American Association Of Clinical Endocrinologists 2010, 16: 730-45. PMID: 21356637, DOI: 10.4158/EP.16.5.730.
• STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.Davis SN, Horton ES, Battelino T, Rubin RR, Schulman KA, Tamborlane WV. STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects. Diabetes Technology & Therapeutics 2010, 12: 249-55. PMID: 20210562, PMCID: PMC2883476, DOI: 10.1089/dia.2009.0145.
• The cost-effectiveness of continuous glucose monitoring in type 1 diabetes.Huang ES, O'Grady M, Basu A, Winn A, John P, Lee J, Meltzer D, Kollman C, Laffel L, Tamborlane W, Weinzimer S, Wysocki T. The cost-effectiveness of continuous glucose monitoring in type 1 diabetes. Diabetes Care 2010, 33: 1269-74. PMID: 20332354, PMCID: PMC2875436, DOI: 10.2337/dc09-2042.
• Perception of the impact of type 1 diabetes on low-income families.Edmonds-Myles S, Tamborlane WV, Grey M. Perception of the impact of type 1 diabetes on low-income families. The Diabetes Educator 2010, 36: 318-25. PMID: 20410369, DOI: 10.1177/0145721709349219.
• Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial.Beck RW, Lawrence JM, Laffel L, Wysocki T, Xing D, Huang ES, Ives B, Kollman C, Lee J, Ruedy KJ, Tamborlane WV. Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care 2010, 33: 2175-7. PMID: 20696865, PMCID: PMC2945155, DOI: 10.2337/dc10-0331.
• Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.Chase HP, Beck RW, Xing D, Tamborlane WV, Coffey J, Fox LA, Ives B, Keady J, Kollman C, Laffel L, Ruedy KJ. Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technology & Therapeutics 2010, 12: 507-15. PMID: 20597824, DOI: 10.1089/dia.2010.0021.
• Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset.Fiallo-Scharer R, Cheng J, Beck RW, Buckingham BA, Chase HP, Kollman C, Laffel L, Lawrence JM, Mauras N, Tamborlane WV, Wilson DM, Wolpert H. Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset. Diabetes Care 2011, 34: 586-90. PMID: 21266651, PMCID: PMC3041185, DOI: 10.2337/dc10-1111.
• Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring.Xing D, Kollman C, Beck RW, Tamborlane WV, Laffel L, Buckingham BA, Wilson DM, Weinzimer S, Fiallo-Scharer R, Ruedy KJ. Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring. Diabetes Technology & Therapeutics 2011, 13: 351-8. PMID: 21299401, PMCID: PMC6468940, DOI: 10.1089/dia.2010.0156.
• Long-term results of an obesity program in an ethnically diverse pediatric population.Savoye M, Nowicka P, Shaw M, Yu S, Dziura J, Chavent G, O'Malley G, Serrecchia JB, Tamborlane WV, Caprio S. Long-term results of an obesity program in an ethnically diverse pediatric population. Pediatrics 2011, 127: 402-10. PMID: 21300674, PMCID: PMC3065145, DOI: 10.1542/peds.2010-0697.
• Severe hypoglycemia in youth with T1DM: going, going … but not yet gone.Tamborlane WV. Severe hypoglycemia in youth with T1DM: going, going … but not yet gone. Pediatric Diabetes 2011, 12: 1-3. PMID: 21265956, DOI: 10.1111/j.1399-5448.2010.00754.x.
• Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.Wilson DM, Xing D, Beck RW, Block J, Bode B, Fox LA, Hirsch I, Kollman C, Laffel L, Ruedy KJ, Steffes M, Tamborlane WV. Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Care 2011, 34: 540-4. PMID: 21266647, PMCID: PMC3041177, DOI: 10.2337/dc10-1054.
• Health utilities for children and adults with type 1 diabetes.Lee JM, Rhee K, O'grady MJ, Basu A, Winn A, John P, Meltzer DO, Kollman C, Laffel LM, Lawrence JM, Tamborlane WV, Wysocki T, Xing D, Huang ES. Health utilities for children and adults with type 1 diabetes. Medical Care 2011, 49: 924-31. PMID: 21544001, PMCID: PMC3210197, DOI: 10.1097/MLR.0b013e318216592c.
• New-generation diabetes management: glucose sensor-augmented insulin pump therapy.Cengiz E, Sherr JL, Weinzimer SA, Tamborlane WV. New-generation diabetes management: glucose sensor-augmented insulin pump therapy. Expert Review Of Medical Devices 2011, 8: 449-58. PMID: 21728731, PMCID: PMC3177536, DOI: 10.1586/erd.11.22.
• Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline.Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, Wolpert H. Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. The Journal Of Clinical Endocrinology And Metabolism 2011, 96: 2968-79. PMID: 21976745, DOI: 10.1210/jc.2010-2756.
• The Hormone Foundation's: Patient guide to continuous glucose monitoring.Tamborlane WV, Vigersky RA. The Hormone Foundation's: Patient guide to continuous glucose monitoring. The Journal Of Clinical Endocrinology And Metabolism 2011, 96: 29A-30A. PMID: 21976752, DOI: 10.1210/jcem.96.4.zeg29a.
• Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline.Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, Kaufman FR, Linder B, Marcovina S, McGuigan P, Pyle L, Tamborlane W, Willi S. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. The Journal Of Clinical Endocrinology And Metabolism 2011, 96: 159-67. PMID: 20962021, PMCID: PMC3038479, DOI: 10.1210/jc.2010-1642.
• Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase.Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Perkins BA, Welsh JB, Willi SM, Wood MA. Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase. Diabetes Care 2011, 34: 2403-5. PMID: 21933908, PMCID: PMC3198292, DOI: 10.2337/dc11-1248.
• Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes.Tansey M, Laffel L, Cheng J, Beck R, Coffey J, Huang E, Kollman C, Lawrence J, Lee J, Ruedy K, Tamborlane W, Wysocki T, Xing D. Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabetic Medicine : A Journal Of The British Diabetic Association 2011, 28: 1118-22. PMID: 21692844, DOI: 10.1111/j.1464-5491.2011.03368.x.
• A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitus.Cengiz E, Sherr JL, Erkin-Cakmak A, Weinzimer SA, Burke EN, Sikes KA, Urban AD, Tamborlane WV. A bridge to insulin pump therapy: twice-daily regimen with NPH and detemir insulins during initial treatment of youth with type 1 diabetes mellitus. Endocrine Practice : Official Journal Of The American College Of Endocrinology And The American Association Of Clinical Endocrinologists 2011, 17: 862-6. PMID: 21550949, DOI: 10.4158/EP11031.OR.
• The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin.Cengiz E, Swan KL, Tamborlane WV, Sherr JL, Martin M, Weinzimer SA. The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin. Diabetes Care 2012, 35: 690-2. PMID: 22374642, PMCID: PMC3308292, DOI: 10.2337/dc11-0732.
• The landmark JDRF continuous glucose monitoring randomized trials: a look back at the accumulated evidence.Ruedy KJ, Tamborlane WV. The landmark JDRF continuous glucose monitoring randomized trials: a look back at the accumulated evidence. Journal Of Cardiovascular Translational Research 2012, 5: 380-7. PMID: 22538483, DOI: 10.1007/s12265-012-9364-9.
• Insulin therapy in children and adolescents.Tamborlane WV, Sikes KA. Insulin therapy in children and adolescents. Endocrinology And Metabolism Clinics Of North America 2012, 41: 145-60. PMID: 22575411, DOI: 10.1016/j.ecl.2012.01.002.
• Clinical equipoise: an argument for expedited approval of the first small step toward an autonomous artificial pancreas.Cengiz E, Sherr JL, Weinzimer SA, Tamborlane WV. Clinical equipoise: an argument for expedited approval of the first small step toward an autonomous artificial pancreas. Expert Review Of Medical Devices 2012, 9: 315-7. PMID: 22905835, DOI: 10.1586/erd.12.33.
• Effect of insulin feedback on closed-loop glucose control: a crossover study.Ruiz JL, Sherr JL, Cengiz E, Carria L, Roy A, Voskanyan G, Tamborlane WV, Weinzimer SA. Effect of insulin feedback on closed-loop glucose control: a crossover study. Journal Of Diabetes Science And Technology 2012, 6: 1123-30. PMID: 23063039, PMCID: PMC3570847, DOI: 10.1177/193229681200600517.
• The T1D Exchange clinic registry.Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA. The T1D Exchange clinic registry. The Journal Of Clinical Endocrinology And Metabolism 2012, 97: 4383-9. PMID: 22996145, DOI: 10.1210/jc.2012-1561.
• Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study.Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, Tamborlane WV. Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study. Pediatric Diabetes 2012, 13: 6-11. PMID: 21722284, DOI: 10.1111/j.1399-5448.2011.00793.x.
• Closed-loop insulin delivery: we're "virtually" there.Tamborlane WV. Closed-loop insulin delivery: we're "virtually" there. Diabetes Technology & Therapeutics 2012, 14: 203-4. PMID: 22171545, DOI: 10.1089/dia.2011.0261.
• Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function.Sherr J, Tamborlane WV, Xing D, Tsalikian E, Mauras N, Buckingham B, White NH, Arbelaez AM, Beck RW, Kollman C, Ruedy K. Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function. Diabetes Care 2012, 35: 817-20. PMID: 22323414, PMCID: PMC3308298, DOI: 10.2337/dc11-2190.
• A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.Mauras N, Beck R, Xing D, Ruedy K, Buckingham B, Tansey M, White NH, Weinzimer SA, Tamborlane W, Kollman C. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care 2012, 35: 204-10. PMID: 22210571, PMCID: PMC3263860, DOI: 10.2337/dc11-1746.
• Use of continuous glucose monitoring in children and adolescents (*).Phillip M, Danne T, Shalitin S, Buckingham B, Laffel L, Tamborlane W, Battelino T. Use of continuous glucose monitoring in children and adolescents (*). Pediatric Diabetes 2012, 13: 215-28. PMID: 22284160, DOI: 10.1111/j.1399-5448.2011.00849.x.
• Accuracy and precision of the Axis-Shield Afinion hemoglobin A1c measurement device.Wood JR, Kaminski BM, Kollman C, Beck RW, Hall CA, Yun JP, Cengiz E, Haller MJ, Hassan K, Klingensmith GJ, Tamborlane WV. Accuracy and precision of the Axis-Shield Afinion hemoglobin A1c measurement device. Journal Of Diabetes Science And Technology 2012, 6: 380-6. PMID: 22538150, PMCID: PMC3380782, DOI: 10.1177/193229681200600224.
• Effectiveness of a spanish language clinic for Hispanic youth with type 1 diabetes.Palau-Collazo MM, Rose P, Sikes K, Kim G, Benavides V, Urban A, Weinzimer SA, Tamborlane WV. Effectiveness of a spanish language clinic for Hispanic youth with type 1 diabetes. Endocrine Practice : Official Journal Of The American College Of Endocrinology And The American Association Of Clinical Endocrinologists 2013, 19: 800-4. PMID: 23757616, DOI: 10.4158/EP13004.OR.
• Challenges and future directions of the T1D Exchange Clinic Network and registry.Miller KM, Xing D, Tamborlane WV, Bergenstal RM, Beck RW. Challenges and future directions of the T1D Exchange Clinic Network and registry. Journal Of Diabetes Science And Technology 2013, 7: 963-9. PMID: 23911177, PMCID: PMC3879760, DOI: 10.1177/193229681300700418.
• Diabetic ketoacidosis at diabetes onset: still an all too common threat in youth.Klingensmith GJ, Tamborlane WV, Wood J, Haller MJ, Silverstein J, Cengiz E, Shanmugham S, Kollman C, Wong-Jacobson S, Beck RW. Diabetic ketoacidosis at diabetes onset: still an all too common threat in youth. The Journal Of Pediatrics 2013, 162: 330-4.e1. PMID: 22901739, DOI: 10.1016/j.jpeds.2012.06.058.
• Diabetes: Insulin pumps in children with T1DM--we told you so.Tamborlane WV, Sherr JL. Diabetes: Insulin pumps in children with T1DM--we told you so. Nature Reviews. Endocrinology 2013, 9: 629-30. PMID: 24080733, DOI: 10.1038/nrendo.2013.190.
• Effectiveness of early intensive therapy on β-cell preservation in type 1 diabetes.Buckingham B, Beck RW, Ruedy KJ, Cheng P, Kollman C, Weinzimer SA, DiMeglio LA, Bremer AA, Slover R, Tamborlane WV. Effectiveness of early intensive therapy on β-cell preservation in type 1 diabetes. Diabetes Care 2013, 36: 4030-5. PMID: 24130350, PMCID: PMC3836135, DOI: 10.2337/dc13-1074.
• Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children.Kaminski BM, Klingensmith GJ, Beck RW, Tamborlane WV, Lee J, Hassan K, Schatz D, Kollman C, Redondo MJ. Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children. The Journal Of Pediatrics 2013, 162: 736-740.e1. PMID: 23092524, DOI: 10.1016/j.jpeds.2012.09.017.
• Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device.Cengiz E, Weinzimer SA, Sherr JL, Tichy E, Martin M, Carria L, Steffen A, Tamborlane WV. Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device. Pediatric Diabetes 2013, 14: 168-73. PMID: 23107353, PMCID: PMC3572265, DOI: 10.1111/pedi.12001.
• Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes.Lin MH, Connor CG, Ruedy KJ, Beck RW, Kollman C, Buckingham B, Redondo MJ, Schatz D, Haro H, Lee JM, Tamborlane WV, Wood JR. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. Diabetes Technology & Therapeutics 2013, 15: 929-34. PMID: 23869706, PMCID: PMC3817890, DOI: 10.1089/dia.2013.0132.
• Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines.Wood JR, Miller KM, Maahs DM, Beck RW, DiMeglio LA, Libman IM, Quinn M, Tamborlane WV, Woerner SE. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care 2013, 36: 2035-7. PMID: 23340893, PMCID: PMC3687259, DOI: 10.2337/dc12-1959.
• Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP).Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, Deeb L, Dolin RH, Garg SK, Goland R, Hirsch IB, Klonoff DC, Kruger DF, Matfin G, Mazze RS, Olson BA, Parkin C, Peters A, Powers MA, Rodriguez H, Southerland P, Strock ES, Tamborlane W, Wesley DM. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technology & Therapeutics 2013, 15: 198-211. PMID: 23448694, DOI: 10.1089/dia.2013.0051.
• Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D Exchange clinic registry.Daniels M, DuBose SN, Maahs DM, Beck RW, Fox LA, Gubitosi-Klug R, Laffel LM, Miller KM, Speer H, Tamborlane WV, Tansey MJ. Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D Exchange clinic registry. Diabetes Care 2013, 36: 2639-45. PMID: 23610082, PMCID: PMC3747908, DOI: 10.2337/dc12-2192.
• Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile.Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, Deeb L, Dolin RH, Garg SK, Goland R, Hirsch IB, Klonoff DC, Kruger DF, Matfin G, Mazze RS, Olson BA, Parkin C, Peters A, Powers MA, Rodriguez H, Southerland P, Strock ES, Tamborlane W, Wesley DM. Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile. Journal Of Diabetes Science And Technology 2013, 7: 562-78. PMID: 23567014, PMCID: PMC3737658, DOI: 10.1177/193229681300700234.
• Extended 6-month follow-up of a randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.Tansey M, Weinzimer S, Beck R, Ruedy K, Cheng P, Tamborlane W, Kollman C, Mauras N, Fox L, Coffey J, White NH. Extended 6-month follow-up of a randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care 2013, 36: e63. PMID: 23613604, PMCID: PMC3631880, DOI: 10.2337/dc12-2021.
• Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry.Cengiz E, Xing D, Wong JC, Wolfsdorf JI, Haymond MW, Rewers A, Shanmugham S, Tamborlane WV, Willi SM, Seiple DL, Miller KM, DuBose SN, Beck RW. Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatric Diabetes 2013, 14: 447-54. PMID: 23469984, PMCID: PMC4100244, DOI: 10.1111/pedi.12030.
• Incentivizing behaviour change to improve diabetes care.Petry NM, Cengiz E, Wagner JA, Hood KK, Carria L, Tamborlane WV. Incentivizing behaviour change to improve diabetes care. Diabetes, Obesity & Metabolism 2013, 15: 1071-6. PMID: 23574494, PMCID: PMC3737360, DOI: 10.1111/dom.12111.
• Developing parent expertise: A framework to guide parental care following diagnosis of Type 1 Diabetes in a young child.Niedel S, Traynor M, Tamborlane W, Acerini C, McKee M. Developing parent expertise: A framework to guide parental care following diagnosis of Type 1 Diabetes in a young child. Journal Of Health Services Research & Policy 2013 PMID: 23620579, DOI: 10.1177/1355819613475602.
• Status of Diabetes Care: "It just doesn't get any better . . . or does it?".Cefalu WT, Boulton AJ, Tamborlane WV, Moses RG, LeRoith D, Greene EL, Hu FB, Bakris G, Wylie-Rosett J, Rosenstock J, Weinger K, Blonde L, de Groot M, Riddle MC, Henry RR, Hill Golden S, Rich S, Reynolds L. Status of Diabetes Care: "It just doesn't get any better . . . or does it?". Diabetes Care 2014, 37: 1782-5. PMID: 25093231, PMCID: PMC5131856, DOI: 10.2337/dc14-1073.
• The artificial pancreas: are we there yet?Cefalu WT, Tamborlane WV. The artificial pancreas: are we there yet? Diabetes Care 2014, 37: 1182-3. PMID: 24757224, PMCID: PMC5131852, DOI: 10.2337/dc14-0491.
• Joining forces: a call for greater collaboration to study new medicines in children and adolescents with type 2 diabetes.Karres J, Pratt V, Guettier JM, Temeck J, Tamborlane WV, Dunger D, Bejnariu C, De Beaufort C, Tomasi P. Joining forces: a call for greater collaboration to study new medicines in children and adolescents with type 2 diabetes. Diabetes Care 2014, 37: 2665-7. PMID: 25249667, DOI: 10.2337/dc14-0494.
• Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy.Blackman SM, Raghinaru D, Adi S, Simmons JH, Ebner-Lyon L, Chase HP, Tamborlane WV, Schatz DA, Block JM, Litton JC, Raman V, Foster NC, Kollman CR, DuBose SN, Miller KM, Beck RW, DiMeglio LA. Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy. Pediatric Diabetes 2014, 15: 564-72. PMID: 24494980, DOI: 10.1111/pedi.12121.
• Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis.Redondo MJ, Connor CG, Ruedy KJ, Beck RW, Kollman C, Wood JR, Buckingham B, Klingensmith GJ, Silverstein J, Tamborlane WV. Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis. Pediatric Diabetes 2014, 15: 294-302. PMID: 23889707, PMCID: PMC3858510, DOI: 10.1111/pedi.12061.
• Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis.Cengiz E, Connor CG, Ruedy KJ, Beck RW, Kollman C, Klingensmith GJ, Tamborlane WV, Lee JM, Haller MJ. Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis. Pediatric Diabetes 2014, 15: 287-93. PMID: 23944865, PMCID: PMC3844085, DOI: 10.1111/pedi.12068.
• Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus.Arbelaez AM, Xing D, Cryer PE, Kollman C, Beck RW, Sherr J, Ruedy KJ, Tamborlane WV, Mauras N, Tsalikian E, Wilson DM, White NH. Blunted glucagon but not epinephrine responses to hypoglycemia occurs in youth with less than 1 yr duration of type 1 diabetes mellitus. Pediatric Diabetes 2014, 15: 127-34. PMID: 23992543, PMCID: PMC3858506, DOI: 10.1111/pedi.12070.
• A contrast between children and adolescents with excellent and poor control: the T1D Exchange clinic registry experience.Campbell MS, Schatz DA, Chen V, Wong JC, Steck A, Tamborlane WV, Smith J, Beck RW, Cengiz E, Laffel LM, Miller KM, Haller MJ. A contrast between children and adolescents with excellent and poor control: the T1D Exchange clinic registry experience. Pediatric Diabetes 2014, 15: 110-7. PMID: 23957219, PMCID: PMC4164957, DOI: 10.1111/pedi.12067.
• Can we get it right for youth with type 2 diabetes?Tamborlane WV, Ruedy K, Van Name M, Klingensmith GJ. Can we get it right for youth with type 2 diabetes? Diabetes Research And Clinical Practice 2014, 106: 643-4. PMID: 25488379, DOI: 10.1016/j.diabres.2014.11.003.
• Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes.Marzelli MJ, Mazaika PK, Barnea-Goraly N, Hershey T, Tsalikian E, Tamborlane W, Mauras N, White NH, Buckingham B, Beck RW, Ruedy KJ, Kollman C, Cheng P, Reiss AL. Neuroanatomical correlates of dysglycemia in young children with type 1 diabetes. Diabetes 2014, 63: 343-53. PMID: 24170697, PMCID: PMC3868050, DOI: 10.2337/db13-0179.
• Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming.Cengiz E, Weinzimer SA, Sherr JL, Tichy EM, Carria L, Cappiello D, Steffen A, Tamborlane WV. Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming. Diabetes Technology & Therapeutics 2014, 16: 20-5. PMID: 24367934, PMCID: PMC3887414, DOI: 10.1089/dia.2013.0187.
• Evolution of abnormal plasma glucagon responses to mixed-meal feedings in youth with type 1 diabetes during the first 2 years after diagnosis.Sherr J, Tsalikian E, Fox L, Buckingham B, Weinzimer S, Tamborlane WV, White NH, Arbelaez AM, Kollman C, Ruedy KJ, Cheng P, Beck RW. Evolution of abnormal plasma glucagon responses to mixed-meal feedings in youth with type 1 diabetes during the first 2 years after diagnosis. Diabetes Care 2014, 37: 1741-4. PMID: 24696460, PMCID: PMC4030093, DOI: 10.2337/dc13-2612.
• Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force.Grunberger G, Abelseth JM, Bailey TS, Bode BW, Handelsman Y, Hellman R, Jovanovič L, Lane WS, Raskin P, Tamborlane WV, Rothermel C. Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force. Endocrine Practice : Official Journal Of The American College Of Endocrinology And The American Association Of Clinical Endocrinologists 2014, 20: 463-89. PMID: 24816754, DOI: 10.4158/EP14145.PS.
• Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries.Maahs DM, Hermann JM, DuBose SN, Miller KM, Heidtmann B, DiMeglio LA, Rami-Merhar B, Beck RW, Schober E, Tamborlane WV, Kapellen TM, Holl RW. Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries. Diabetologia 2014, 57: 1578-85. PMID: 24893863, DOI: 10.1007/s00125-014-3272-2.
• Depressive Symptoms in Youth With Type 1 or Type 2 Diabetes: Results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study.Silverstein J, Cheng P, Ruedy KJ, Kollman C, Beck RW, Klingensmith GJ, Wood JR, Willi S, Bacha F, Lee J, Cengiz E, Redondo MJ, Tamborlane WV. Depressive Symptoms in Youth With Type 1 or Type 2 Diabetes: Results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study. Diabetes Care 2015, 38: 2341-3. PMID: 26459274, DOI: 10.2337/dc15-0982.
• Testing for rewards: a pilot study to improve type 1 diabetes management in adolescents.Petry NM, Cengiz E, Wagner JA, Weyman K, Tichy E, Tamborlane WV. Testing for rewards: a pilot study to improve type 1 diabetes management in adolescents. Diabetes Care 2015, 38: 1952-4. PMID: 26203061, PMCID: PMC4580608, DOI: 10.2337/dc15-0765.
• Body mass index changes in youth in the first year after type 1 diabetes diagnosis.Gregg B, Connor CG, Ruedy KJ, Beck RW, Kollman C, Schatz D, Cengiz E, Harris B, Tamborlane WV, Klingensmith GJ, Lee JM. Body mass index changes in youth in the first year after type 1 diabetes diagnosis. The Journal Of Pediatrics 2015, 166: 1265-1269.e1. PMID: 25919735, DOI: 10.1016/j.jpeds.2015.02.036.
• Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas.Ang KH, Tamborlane WV, Weinzimer SA. Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas. Expert Opinion On Drug Delivery 2015, 12: 1579-82. PMID: 26389567, PMCID: PMC4837694, DOI: 10.1517/17425247.2015.1074174.
• Type 1 diabetes at a crossroads!Cefalu WT, Tamborlane WV, Skyler JS. Type 1 diabetes at a crossroads! Diabetes Care 2015, 38: 968-70. PMID: 25998288, PMCID: PMC5131855, DOI: 10.2337/dc15-0615.
• Assessing rates of hypoglycemia as an end point in clinical trials.Muchmore DB, Heinemann L, Tamborlane W, Wu XW, Fleming A. Assessing rates of hypoglycemia as an end point in clinical trials. Diabetes Care 2015, 38: e160-1. PMID: 26283738, DOI: 10.2337/dc15-0808.
• Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison.McKnight JA, Wild SH, Lamb MJ, Cooper MN, Jones TW, Davis EA, Hofer S, Fritsch M, Schober E, Svensson J, Almdal T, Young R, Warner JT, Delemer B, Souchon PF, Holl RW, Karges W, Kieninger DM, Tigas S, Bargiota A, Sampanis C, Cherubini V, Gesuita R, Strele I, Pildava S, Coppell KJ, Magee G, Cooper JG, Dinneen SF, Eeg-Olofsson K, Svensson AM, Gudbjornsdottir S, Veeze H, Aanstoot HJ, Khalangot M, Tamborlane WV, Miller KM. Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabetic Medicine : A Journal Of The British Diabetic Association 2015, 32: 1036-50. PMID: 25510978, DOI: 10.1111/dme.12676.
• Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart.Tamborlane WV, Renard E, Wadwa RP, Blevins T, Jacober SJ, Liu R, D'Souza DN, Rees TM. Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart. Journal Of Diabetes 2015, 7: 270-8. PMID: 24734891, DOI: 10.1111/1753-0407.12162.
• Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia.Mauras N, Mazaika P, Buckingham B, Weinzimer S, White NH, Tsalikian E, Hershey T, Cato A, Cheng P, Kollman C, Beck RW, Ruedy K, Aye T, Fox L, Arbelaez AM, Wilson D, Tansey M, Tamborlane W, Peng D, Marzelli M, Winer KK, Reiss AL. Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes 2015, 64: 1770-9. PMID: 25488901, PMCID: PMC4407847, DOI: 10.2337/db14-1445.
• Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States.DuBose SN, Hermann JM, Tamborlane WV, Beck RW, Dost A, DiMeglio LA, Schwab KO, Holl RW, Hofer SE, Maahs DM. Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States. The Journal Of Pediatrics 2015, 167: 627-32.e1-4. PMID: 26164381, DOI: 10.1016/j.jpeds.2015.05.046.
• CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes.Buckingham B, Cheng P, Beck RW, Kollman C, Ruedy KJ, Weinzimer SA, Slover R, Bremer AA, Fuqua J, Tamborlane W. CGM-measured glucose values have a strong correlation with C-peptide, HbA1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes. Diabetologia 2015, 58: 1167-74. PMID: 25773405, PMCID: PMC4416994, DOI: 10.1007/s00125-015-3559-y.
• Improved Postprandial Glucose Control Using the InsuPad Device in Insulin-Treated Type 2 Diabetes: Injection Site Warming to Improve Glycemic Control.Raz I, Bitton G, Feldman D, Alon T, Pfutzner A, Tamborlane WV. Improved Postprandial Glucose Control Using the InsuPad Device in Insulin-Treated Type 2 Diabetes: Injection Site Warming to Improve Glycemic Control. Journal Of Diabetes Science And Technology 2015, 9: 639-43. PMID: 25883166, PMCID: PMC4604546, DOI: 10.1177/1932296815578881.
• Racial-ethnic disparities in management and outcomes among children with type 1 diabetes.Willi SM, Miller KM, DiMeglio LA, Klingensmith GJ, Simmons JH, Tamborlane WV, Nadeau KJ, Kittelsrud JM, Huckfeldt P, Beck RW, Lipman TH. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics 2015, 135: 424-34. PMID: 25687140, PMCID: PMC4533245, DOI: 10.1542/peds.2014-1774.
• Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.Libman IM, Miller KM, DiMeglio LA, Bethin KE, Katz ML, Shah A, Simmons JH, Haller MJ, Raman S, Tamborlane WV, Coffey JK, Saenz AM, Beck RW, Nadeau KJ. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. JAMA 2015, 314: 2241-50. PMID: 26624824, DOI: 10.1001/jama.2015.16174.
• Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, DiMeglio LA, Maahs DM, Tamborlane WV. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care 2015, 38: 971-8. PMID: 25998289, DOI: 10.2337/dc15-0078.
• Building Momentum: Taking on the Real “Issues” of Diabetes Care!Cefalu WT, Boulton AJ, Tamborlane WV, Moses RG, LeRoith D, Greene EL, Hu FB, Bakris G, Wylie-Rosett J, Rosenstock J, Weinger K, Blonde L, de Groot M, Riddle MC, Hill Golden S, Rich SS, D'Alessio D, Reynolds L. Building Momentum: Taking on the Real “Issues” of Diabetes Care! Diabetes Care 2016, 39: 10-12. PMID: 27606379, PMCID: PMC4822403, DOI: 10.2337/dc15-2315.
• Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections.Foster NC, Miller KM, Tamborlane WV, Bergenstal RM, Beck RW. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections. Diabetes Care 2016, 39: e81-2. PMID: 27208319, PMCID: PMC5317243, DOI: 10.2337/dc16-0207.
• Characteristics of youth with type 1 diabetes (T1D) with and without a parent with T1D in the T1D exchange clinic registry.Fox LA, Mubasher M, Wolfsdorf JI, Buckingham BA, Peters AL, Tamborlane WV, Schatz DA, Maahs DM, Miller KM, Beck RW. Characteristics of youth with type 1 diabetes (T1D) with and without a parent with T1D in the T1D exchange clinic registry. Journal Of Diabetes 2016, 8: 834-838. PMID: 26663683, DOI: 10.1111/1753-0407.12363.
• Diabetes Care: "Lagniappe" and "Seeing Is Believing"!Cefalu WT, Boulton AJ, Tamborlane WV, Moses RG, LeRoith D, Greene EL, Hu FB, Bakris G, Wylie-Rosett J, Rosenstock J, Weinger K, Blonde L, de Groot M, Rich SS, D'Alessio D, Riddle MC, Reynolds L. Diabetes Care: "Lagniappe" and "Seeing Is Believing"! Diabetes Care 2016, 39: 1069-71. PMID: 27631957, PMCID: PMC5013720, DOI: 10.2337/dc16-0891.
• Life With Type 1 Diabetes: Views of Hispanic Adolescents and Their Clinicians.Reitblat L, Whittemore R, Weinzimer SA, Tamborlane WV, Sadler LS. Life With Type 1 Diabetes: Views of Hispanic Adolescents and Their Clinicians. The Diabetes Educator 2016, 42: 408-17. PMID: 27161932, DOI: 10.1177/0145721716647489.
• Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.Gubitosi-Klug RA, Sun W, Cleary PA, Braffett BH, Aiello LP, Das A, Tamborlane W, Klein R. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort. JAMA Ophthalmology 2016, 134: 137-45. PMID: 26584339, PMCID: PMC4825807, DOI: 10.1001/jamaophthalmol.2015.4606.
• The past, present, and future of basal insulins.Pettus J, Santos Cavaiola T, Tamborlane WV, Edelman S. The past, present, and future of basal insulins. Diabetes/metabolism Research And Reviews 2016, 32: 478-96. PMID: 26509843, DOI: 10.1002/dmrr.2763.
• Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.Sherr JL, Ruedy KJ, Foster NC, Piché CA, Dulude H, Rickels MR, Tamborlane WV, Bethin KE, DiMeglio LA, Fox LA, Wadwa RP, Schatz DA, Nathan BM, Marcovina SM, Rampakakis E, Meng L, Beck RW. Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes. Diabetes Care 2016, 39: 555-62. PMID: 26884472, PMCID: PMC4806770, DOI: 10.2337/dc15-1606.
• Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index.Redondo MJ, Foster NC, Libman IM, Mehta SN, Hathway JM, Bethin KE, Nathan BM, Ecker MA, Shah AC, DuBose SN, Tamborlane WV, Hoffman RP, Wong JC, Maahs DM, Beck RW, DiMeglio LA. Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index. Acta Diabetologica 2016, 53: 271-7. PMID: 26077171, DOI: 10.1007/s00592-015-0785-1.
• Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry.Clements MA, Foster NC, Maahs DM, Schatz DA, Olson BA, Tsalikian E, Lee JM, Burt-Solorzano CM, Tamborlane WV, Chen V, Miller KM, Beck RW. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. Pediatric Diabetes 2016, 17: 327-36. PMID: 26153338, DOI: 10.1111/pedi.12295.
• The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes.Kovatchev B, Tamborlane WV, Cefalu WT, Cobelli C. The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes. Diabetes Care 2016, 39: 1123-6. PMID: 27330124, PMCID: PMC4915552, DOI: 10.2337/dc16-0824.
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT.Bailey TS, Grunberger G, Bode BW, Handelsman Y, Hirsch IB, Jovanovič L, Roberts VL, Rodbard D, Tamborlane WV, Walsh J. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT. Endocrine Practice : Official Journal Of The American College Of Endocrinology And The American Association Of Clinical Endocrinologists 2016, 22: 231-61. PMID: 26848630, DOI: 10.4158/EP151124.CS.
• C-peptide levels in pediatric type 2 diabetes in the Pediatric Diabetes Consortium T2D Clinic Registry.Gregg B, Connor CG, Cheng P, Ruedy KJ, Beck RW, Kollman C, Schatz D, Cengiz E, Tamborlane WV, Klingensmith GJ, Lee JM. C-peptide levels in pediatric type 2 diabetes in the Pediatric Diabetes Consortium T2D Clinic Registry. Pediatric Diabetes 2016, 17: 274-80. PMID: 25940861, DOI: 10.1111/pedi.12280.
• Therapeutic inertia: underdiagnosed and undertreated hypertension in children participating in the T1D Exchange Clinic Registry.Nambam B, DuBose SN, Nathan BM, Beck RW, Maahs DM, Wadwa RP, Tamborlane WV, Foster NC, Miller KM, Haller MJ. Therapeutic inertia: underdiagnosed and undertreated hypertension in children participating in the T1D Exchange Clinic Registry. Pediatric Diabetes 2016, 17: 15-20. PMID: 25330905, DOI: 10.1111/pedi.12231.
• Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities.Nadeau KJ, Anderson BJ, Berg EG, Chiang JL, Chou H, Copeland KC, Hannon TS, Huang TT, Lynch JL, Powell J, Sellers E, Tamborlane WV, Zeitler P. Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities. Diabetes Care 2016, 39: 1635-42. PMID: 27486237, PMCID: PMC5314694, DOI: 10.2337/dc16-1066.
• Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide.Sherr JL, Patel NS, Michaud CI, Palau-Collazo MM, Van Name MA, Tamborlane WV, Cengiz E, Carria LR, Tichy EM, Weinzimer SA. Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide. Diabetes Care 2016, 39: 1127-34. PMID: 27208332, PMCID: PMC4915555, DOI: 10.2337/dc16-0089.
• Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries.Sherr JL, Hermann JM, Campbell F, Foster NC, Hofer SE, Allgrove J, Maahs DM, Kapellen TM, Holman N, Tamborlane WV, Holl RW, Beck RW, Warner JT. Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries. Diabetologia 2016, 59: 87-91. PMID: 26546085, DOI: 10.1007/s00125-015-3790-6.
• Expanding Treatment Options for Youth With Type 2 Diabetes: Current Problems and Proposed Solutions: A White Paper From the NICHD Diabetes Working Group.Tamborlane WV, Haymond MW, Dunger D, Shankar R, Gubitosi-Klug R, Bethin K, Karres J, Tomasi P, Libman I, Hale PH, Portman R, Klingensmith G, Reed M, Blumer J, Giacoia G. Expanding Treatment Options for Youth With Type 2 Diabetes: Current Problems and Proposed Solutions: A White Paper From the NICHD Diabetes Working Group. Diabetes Care 2016, 39: 323-9. PMID: 26908928, PMCID: PMC4764039, DOI: 10.2337/dc15-1649.
• Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.Bergenstal RM, Garg S, Weinzimer SA, Buckingham BA, Bode BW, Tamborlane WV, Kaufman FR. Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes. JAMA 2016, 316: 1407-1408. PMID: 27629148, DOI: 10.1001/jama.2016.11708.
• No Summer Vacation From Diabetes: Glycemic Control in Pediatric Participants in the T1D Exchange Registry Based on Time of Year.Sherr JL, Boyle CT, Miller KM, Beck RW, Tamborlane WV. No Summer Vacation From Diabetes: Glycemic Control in Pediatric Participants in the T1D Exchange Registry Based on Time of Year. Diabetes Care 2016, 39: e214-e215. PMID: 27703027, PMCID: PMC5321252, DOI: 10.2337/dc16-1522.
• Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes.Mazaika PK, Weinzimer SA, Mauras N, Buckingham B, White NH, Tsalikian E, Hershey T, Cato A, Aye T, Fox L, Wilson DM, Tansey MJ, Tamborlane W, Peng D, Raman M, Marzelli M, Reiss AL. Variations in Brain Volume and Growth in Young Children With Type 1 Diabetes. Diabetes 2016, 65: 476-85. PMID: 26512024, PMCID: PMC4747456, DOI: 10.2337/db15-1242.
• Persistently high glucose levels in young children with type 1 diabetes.Tansey M, Beck R, Ruedy K, Tamborlane W, Cheng P, Kollman C, Fox L, Weinzimer S, Mauras N, White N, Tsalikian E. Persistently high glucose levels in young children with type 1 diabetes. Pediatric Diabetes 2016, 17: 93-100. PMID: 25496062, PMCID: PMC4465416, DOI: 10.1111/pedi.12248.
• UTILITY OF PSYCHOLOGICAL SCREENING OF YOUNG ADULTS WITH TYPE 1 DIABETES TRANSITIONING TO ADULT PROVIDERS.Quinn SM, Ambrosino JM, Doyle EA, Weyman K, Tamborlane WV, Jastreboff AM. UTILITY OF PSYCHOLOGICAL SCREENING OF YOUNG ADULTS WITH TYPE 1 DIABETES TRANSITIONING TO ADULT PROVIDERS. Endocrine Practice : Official Journal Of The American College Of Endocrinology And The American Association Of Clinical Endocrinologists 2016, 22: 1104-10. PMID: 27295017, DOI: 10.4158/EP151190.OR.
• Effective Translation of an Intensive Lifestyle Intervention for Hispanic Women With Prediabetes in a Community Health Center Setting.Van Name MA, Camp AW, Magenheimer EA, Li F, Dziura JD, Montosa A, Patel A, Tamborlane WV. Effective Translation of an Intensive Lifestyle Intervention for Hispanic Women With Prediabetes in a Community Health Center Setting. Diabetes Care 2016, 39: 525-31. PMID: 26908915, PMCID: PMC4806769, DOI: 10.2337/dc15-1899.
• Vitamin D status in youth with type 1 and type 2 diabetes enrolled in the Pediatric Diabetes Consortium (PDC) is not worse than in youth without diabetes.Wood JR, Connor CG, Cheng P, Ruedy KJ, Tamborlane WV, Klingensmith G, Schatz D, Gregg B, Cengiz E, Willi S, Bacha F, Beck RW. Vitamin D status in youth with type 1 and type 2 diabetes enrolled in the Pediatric Diabetes Consortium (PDC) is not worse than in youth without diabetes. Pediatric Diabetes 2016, 17: 584-591. PMID: 26611890, PMCID: PMC4882286, DOI: 10.1111/pedi.12340.
• Moving toward the ideal insulin for insulin pumps.Cengiz E, Bode B, Van Name M, Tamborlane WV. Moving toward the ideal insulin for insulin pumps. Expert Review Of Medical Devices 2016, 13: 57-69. PMID: 26560137, DOI: 10.1586/17434440.2016.1109442.
• Treatable Diabetic Retinopathy Is Extremely Rare Among Pediatric T1D Exchange Clinic Registry Participants.Beauchamp G, Boyle CT, Tamborlane WV, Miller KM, Libman IM, Haller MJ, Beck RW. Treatable Diabetic Retinopathy Is Extremely Rare Among Pediatric T1D Exchange Clinic Registry Participants. Diabetes Care 2016, 39: e218-e219. PMID: 27852686, PMCID: PMC5321251, DOI: 10.2337/dc16-1691.
• Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270.Rickels MR, Ruedy KJ, Foster NC, Piché CA, Dulude H, Sherr JL, Tamborlane WV, Bethin KE, DiMeglio LA, Wadwa RP, Ahmann AJ, Haller MJ, Nathan BM, Marcovina SM, Rampakakis E, Meng L, Beck RW. Response to Comment on Rickels et al. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016;39:264-270. Diabetes Care 2016, 39: e193-4. PMID: 27660135, PMCID: PMC5033081, DOI: 10.2337/dci16-0025.
• Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study.Kelsey MM, Geffner ME, Guandalini C, Pyle L, Tamborlane WV, Zeitler PS, White NH. Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study. Pediatric Diabetes 2016, 17: 212-21. PMID: 25690268, PMCID: PMC4539288, DOI: 10.1111/pedi.12264.
• CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY.Fonseca VA, Grunberger G, Anhalt H, Bailey TS, Blevins T, Garg SK, Handelsman Y, Hirsch IB, Orzeck EA, Roberts VL, Tamborlane W. CONTINUOUS GLUCOSE MONITORING: A CONSENSUS CONFERENCE OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY. Endocrine Practice : Official Journal Of The American College Of Endocrinology And The American Association Of Clinical Endocrinologists 2016, 22: 1008-21. PMID: 27214060, DOI: 10.4158/EP161392.CS.
• Mitigating Reductions in Glucose During Exercise on Closed-Loop Insulin Delivery: The Ex-Snacks Study.Patel NS, Van Name MA, Cengiz E, Carria LR, Tichy EM, Weyman K, Weinzimer SA, Tamborlane WV, Sherr JL. Mitigating Reductions in Glucose During Exercise on Closed-Loop Insulin Delivery: The Ex-Snacks Study. Diabetes Technology & Therapeutics 2016, 18: 794-799. PMID: 27996320, PMCID: PMC5178000, DOI: 10.1089/dia.2016.0311.
• Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.Rickels MR, Ruedy KJ, Foster NC, Piché CA, Dulude H, Sherr JL, Tamborlane WV, Bethin KE, DiMeglio LA, Wadwa RP, Ahmann AJ, Haller MJ, Nathan BM, Marcovina SM, Rampakakis E, Meng L, Beck RW. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care 2016, 39: 264-70. PMID: 26681725, PMCID: PMC4722945, DOI: 10.2337/dc15-1498.
• The need for research addressing alcohol use disorder and diabetes.Walter KN, Wagner JA, Cengiz E, Tamborlane WV, Petry NM. The need for research addressing alcohol use disorder and diabetes. Addiction (Abingdon, England) 2016, 111: 763-5. PMID: 26589363, DOI: 10.1111/add.13187.
• Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium.Klingensmith GJ, Connor CG, Ruedy KJ, Beck RW, Kollman C, Haro H, Wood JR, Lee JM, Willi SM, Cengiz E, Tamborlane WV. Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium. Pediatric Diabetes 2016, 17: 266-73. PMID: 25951940, DOI: 10.1111/pedi.12281.
• Altered Patterns of Early Metabolic Decompensation in Type 1 Diabetes During Treatment with a SGLT2 Inhibitor: An Insulin Pump Suspension Study.Patel NS, Van Name MA, Cengiz E, Carria LR, Weinzimer SA, Tamborlane WV, Sherr JL. Altered Patterns of Early Metabolic Decompensation in Type 1 Diabetes During Treatment with a SGLT2 Inhibitor: An Insulin Pump Suspension Study. Diabetes Technology & Therapeutics 2017, 19: 618-622. PMID: 29068709, PMCID: PMC5689123, DOI: 10.1089/dia.2017.0267.
• Diabetes Care: "Taking It to the Limit One More Time".Cefalu WT, Boulton AJ, Tamborlane WV, Moses RG, LeRoith D, Greene EL, Hu FB, Bakris G, Wylie-Rosett J, Rosenstock J, Kahn SE, Weinger K, Blonde L, de Groot M, Rich S, D'Alessio D, Reynolds L, Riddle MC. Diabetes Care: "Taking It to the Limit One More Time". Diabetes Care 2017, 40: 3-6. PMID: 27999000, PMCID: PMC5180460, DOI: 10.2337/dc16-2326.
• International Consensus on Use of Continuous Glucose Monitoring.Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M. International Consensus on Use of Continuous Glucose Monitoring. Diabetes Care 2017, 40: 1631-1640. PMID: 29162583, PMCID: PMC6467165, DOI: 10.2337/dc17-1600.
• POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRY.Peters A, Van Name MA, Thorsted BL, Piltoft JS, Tamborlane WV. POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRY. Endocrine Practice : Official Journal Of The American College Of Endocrinology And The American Association Of Clinical Endocrinologists 2017, 23: 1201-1209. PMID: 28704103, DOI: 10.4158/EP171813.OR.
• Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.Nathan DM, Bebu I, Hainsworth D, Klein R, Tamborlane W, Lorenzi G, Gubitosi-Klug R, Lachin JM. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes. The New England Journal Of Medicine 2017, 376: 1507-1516. PMID: 28423305, PMCID: PMC5557280, DOI: 10.1056/NEJMoa1612836.
• Stress and Coping Predicts Adjustment and Glycemic Control in Adolescents with Type 1 Diabetes.Jaser SS, Patel N, Xu M, Tamborlane WV, Grey M. Stress and Coping Predicts Adjustment and Glycemic Control in Adolescents with Type 1 Diabetes. Annals Of Behavioral Medicine : A Publication Of The Society Of Behavioral Medicine 2017, 51: 30-38. PMID: 27496164, PMCID: PMC5253083, DOI: 10.1007/s12160-016-9825-5.
• Barriers to participation in industry-sponsored clinical trials in pediatric type 2 diabetes.Farrell R, Bethin K, Klingensmith G, Tamborlane WV, Gubitosi-Klug R. Barriers to participation in industry-sponsored clinical trials in pediatric type 2 diabetes. Pediatric Diabetes 2017, 18: 574-578. PMID: 27807915, DOI: 10.1111/pedi.12465.
• A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry.Nambam B, Silverstein J, Cheng P, Ruedy KJ, Beck RW, Paul Wadwa R, Klingensmith G, Willi SM, Wood JR, Bacha F, Thomas IH, Tamborlane WV. A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry. Pediatric Diabetes 2017, 18: 222-229. PMID: 26970319, DOI: 10.1111/pedi.12377.
• Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers.Commissariat PV, Boyle CT, Miller KM, Mantravadi MG, DeSalvo DJ, Tamborlane WV, Van Name MA, Anderson BJ, DiMeglio LA, Laffel LM. Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers. Diabetes Technology & Therapeutics 2017, 19: 363-369. PMID: 28581817, PMCID: PMC6435342, DOI: 10.1089/dia.2016.0375.
• Disordered Eating Behaviors in Emerging Adults With Type 1 Diabetes: A Common Problem for Both Men and Women.Doyle EA, Quinn SM, Ambrosino JM, Weyman K, Tamborlane WV, Jastreboff AM. Disordered Eating Behaviors in Emerging Adults With Type 1 Diabetes: A Common Problem for Both Men and Women. Journal Of Pediatric Health Care : Official Publication Of National Association Of Pediatric Nurse Associates & Practitioners 2017, 31: 327-333. PMID: 27843015, DOI: 10.1016/j.pedhc.2016.10.004.
• Continuous Glucose Monitoring in Very Preterm Infants: A Randomized Controlled Trial.Galderisi A, Facchinetti A, Steil GM, Ortiz-Rubio P, Cavallin F, Tamborlane WV, Baraldi E, Cobelli C, Trevisanuto D. Continuous Glucose Monitoring in Very Preterm Infants: A Randomized Controlled Trial. Pediatrics 2017, 140 PMID: 28916591, DOI: 10.1542/peds.2017-1162.
• Understanding bolus insulin dose timing: the characteristics and experiences of people with diabetes who take bolus insulin.Tamborlane WV, Pfeiffer KM, Brod M, Nikolajsen A, Sandberg A, Peters AL, Van Name M. Understanding bolus insulin dose timing: the characteristics and experiences of people with diabetes who take bolus insulin. Current Medical Research And Opinion 2017, 33: 639-645. PMID: 28008782, DOI: 10.1080/03007995.2016.1275937.
• Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study.Gubitosi-Klug RA, Braffett BH, White NH, Sherwin RS, Service FJ, Lachin JM, Tamborlane WV. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2017, 40: 1010-1016. PMID: 28550194, PMCID: PMC5521975, DOI: 10.2337/dc16-2723.
• Predictors of Loss to Follow-Up among Children with Type 2 Diabetes.Shoemaker A, Cheng P, Gal RL, Kollman C, Tamborlane WV, Klingensmith GJ, Clements MA, Hannon TS, Heptulla R, Less J, Wood J. Predictors of Loss to Follow-Up among Children with Type 2 Diabetes. Hormone Research In Pædiatrics 2017, 87: 377-384. PMID: 28505610, DOI: 10.1159/000475595.
• Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, Brazg RL, Ilany J, Slover RH, Anderson SM, Bergenstal RM, Grosman B, Roy A, Cordero TL, Shin J, Lee SW, Kaufman FR. Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics 2017, 19: 155-163. PMID: 28134564, PMCID: PMC5359676, DOI: 10.1089/dia.2016.0421.
• Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.Cengiz E, Cheng P, Ruedy KJ, Kollman C, Tamborlane WV, Klingensmith GJ, Gal RL, Silverstein J, Lee J, Redondo MJ, Beck RW. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study. Pediatric Diabetes 2017, 18: 566-573. PMID: 27758023, PMCID: PMC5397378, DOI: 10.1111/pedi.12459.
• Substance Use Disorders among Patients with Type 2 Diabetes: a Dangerous but Understudied Combination.Walter KN, Wagner JA, Cengiz E, Tamborlane WV, Petry NM. Substance Use Disorders among Patients with Type 2 Diabetes: a Dangerous but Understudied Combination. Current Diabetes Reports 2017, 17: 2. PMID: 28101793, DOI: 10.1007/s11892-017-0832-0.
• Psychosocial predictors and moderators of weight management programme outcomes in ethnically diverse obese youth.Taylor JH, Xu Y, Li F, Shaw M, Dziura J, Caprio S, Tamborlane WV, Nowicka P, Savoye M. Psychosocial predictors and moderators of weight management programme outcomes in ethnically diverse obese youth. Pediatric Obesity 2017, 12: 453-461. PMID: 27384496, PMCID: PMC5568975, DOI: 10.1111/ijpo.12165.
• Randomized, double-blind, placebo-controlled dose-finding study of the dipeptidyl peptidase-4 inhibitor linagliptin in pediatric patients with type 2 diabetes.Tamborlane WV, Laffel LM, Weill J, Gordat M, Neubacher D, Retlich S, Hettema W, Hoesl CE, Kaspers S, Marquard J. Randomized, double-blind, placebo-controlled dose-finding study of the dipeptidyl peptidase-4 inhibitor linagliptin in pediatric patients with type 2 diabetes. Pediatric Diabetes 2018, 19: 640-648. PMID: 29171139, DOI: 10.1111/pedi.12616.
• Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry.Bacha F, Cheng P, Gal RL, Kollman C, Tamborlane WV, Klingensmith GJ, Manseau K, Wood J, Beck RW. Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry. Hormone Research In Pædiatrics 2018, 89: 47-55. PMID: 29131017, DOI: 10.1159/000481687.
• Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes.Galderisi A, Sherr J, VanName M, Carria L, Zgorski M, Tichy E, Weyman K, Cengiz E, Weinzimer S, Tamborlane W. Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes. The Journal Of Clinical Endocrinology And Metabolism 2018, 103: 1088-1094. PMID: 29211871, PMCID: PMC6276715, DOI: 10.1210/jc.2017-02265.
• Schooling diabetes: Use of continuous glucose monitoring and remote monitors in the home and school settings.Erie C, Van Name MA, Weyman K, Weinzimer SA, Finnegan J, Sikes K, Tamborlane WV, Sherr JL. Schooling diabetes: Use of continuous glucose monitoring and remote monitors in the home and school settings. Pediatric Diabetes 2018, 19: 92-97. PMID: 28303678, PMCID: PMC5601025, DOI: 10.1111/pedi.12518.
• Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes.Van Name MA, Hilliard ME, Boyle CT, Miller KM, DeSalvo DJ, Anderson BJ, Laffel LM, Woerner SE, DiMeglio LA, Tamborlane WV. Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes. Pediatric Diabetes 2018, 19: 114-120. PMID: 28429581, PMCID: PMC5650950, DOI: 10.1111/pedi.12525.
• Pharmacokinetics and pharmacodynamics of canagliflozin in pediatric patients with type 2 diabetes.Tamborlane WV, Polidori D, Argenti D, Di Prospero NA. Pharmacokinetics and pharmacodynamics of canagliflozin in pediatric patients with type 2 diabetes. Pediatric Diabetes 2018, 19: 649-655. PMID: 29271103, DOI: 10.1111/pedi.12626.
• Substance Use in Adults With Type 1 Diabetes in the T1D Exchange.Petry NM, Foster NC, Cengiz E, Tamborlane WV, Wagner J, Polsky S. Substance Use in Adults With Type 1 Diabetes in the T1D Exchange. The Diabetes Educator 2018, 44: 510-518. PMID: 30203721, DOI: 10.1177/0145721718799088.
• The present and future treatment of pediatric type 2 diabetes.Van Name MA, Guandalini C, Steffen A, Patel A, Tamborlane W. The present and future treatment of pediatric type 2 diabetes. Expert Review Of Endocrinology & Metabolism 2018, 13: 207-212. PMID: 30063424, DOI: 10.1080/17446651.2018.1499467.
• Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry.Tamborlane WV, Chang P, Kollman C, Klingensmith GJ, Ruedy K, Gal RL, Van Name M, Bacha F, Willi S, Beck RW. Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry. Pediatric Diabetes 2018, 19: 1379-1384. PMID: 30175440, DOI: 10.1111/pedi.12763.
• Persistence of abnormalities in white matter in children with type 1 diabetes.Fox LA, Hershey T, Mauras N, Arbeláez AM, Tamborlane WV, Buckingham B, Tsalikian E, Englert K, Raman M, Jo B, Shen H, Reiss A, Mazaika P. Persistence of abnormalities in white matter in children with type 1 diabetes. Diabetologia 2018, 61: 1538-1547. PMID: 29654376, PMCID: PMC5991628, DOI: 10.1007/s00125-018-4610-6.
• Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes.Bjornstad P, Laffel L, Tamborlane WV, Simons G, Hantel S, von Eynatten M, George J, Marquard J, Cherney DZI. Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes. Diabetes Care 2018, 41: e129-e130. PMID: 29941496, PMCID: PMC6054503, DOI: 10.2337/dc18-0394.
• Adolescent type 2 diabetes: Comparing the Pediatric Diabetes Consortium and Germany/Austria/Luxemburg Pediatric Diabetes Prospective registries.Klingensmith GJ, Lanzinger S, Tamborlane WV, Hofer SE, Cheng P, de Beaufort C, Gal RL, Reinehr T, Kollman C, Holl RW. Adolescent type 2 diabetes: Comparing the Pediatric Diabetes Consortium and Germany/Austria/Luxemburg Pediatric Diabetes Prospective registries. Pediatric Diabetes 2018, 19: 1156-1163. PMID: 29923263, DOI: 10.1111/pedi.12712.
• Big Topics for Diabetes Care in 2018: Clinical Guidelines, Costs of Diabetes, and Information Technology.Riddle MC, Bakris G, Boulton AJM, Blonde L, D'Alessio D, Greene EL, de Groot M, Hood K, Hu FB, Kahn SE, Kaul S, LeRoith D, Moses RG, Rich SS, Rosenstock J, Tamborlane WV, Wylie-Rosett J, Reynolds L. Big Topics for Diabetes Care in 2018: Clinical Guidelines, Costs of Diabetes, and Information Technology. Diabetes Care 2018, 41: 1327-1329. PMID: 29934474, DOI: 10.2337/dci18-0035.
• Pharmacokinetic and pharmacodynamic profile of the sodium-glucose co-transporter-2 inhibitor empagliflozin in young people with Type 2 diabetes: a randomized trial.Laffel LMB, Tamborlane WV, Yver A, Simons G, Wu J, Nock V, Hobson D, Hughan KS, Kaspers S, Marquard J. Pharmacokinetic and pharmacodynamic profile of the sodium-glucose co-transporter-2 inhibitor empagliflozin in young people with Type 2 diabetes: a randomized trial. Diabetic Medicine : A Journal Of The British Diabetic Association 2018, 35: 1096-1104. PMID: 29655290, PMCID: PMC6099360, DOI: 10.1111/dme.13629.
• State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.Foster NC, Beck RW, Miller KM, Clements MA, Rickels MR, DiMeglio LA, Maahs DM, Tamborlane WV, Bergenstal R, Smith E, Olson BA, Garg SK. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. Diabetes Technology & Therapeutics 2019, 21: 66-72. PMID: 30657336, PMCID: PMC7061293, DOI: 10.1089/dia.2018.0384.
• Reversal of Ketosis in Type 1 Diabetes Is Not Adversely Affected by SGLT2 Inhibitor Therapy.Siebel S, Galderisi A, Patel NS, Carria LR, Tamborlane WV, Sherr JL. Reversal of Ketosis in Type 1 Diabetes Is Not Adversely Affected by SGLT2 Inhibitor Therapy. Diabetes Technology & Therapeutics 2019, 21: 101-104. PMID: 30688521, PMCID: PMC6434586, DOI: 10.1089/dia.2018.0356.
• Pharmacologic treatment options for type 1 diabetes: what's new?Nally LM, Sherr JL, Van Name MA, Patel AD, Tamborlane WV. Pharmacologic treatment options for type 1 diabetes: what's new? Expert Review Of Clinical Pharmacology 2019, 12: 471-479. PMID: 30892094, PMCID: PMC6488361, DOI: 10.1080/17512433.2019.1597705.
• Risk Factors for Kidney Disease in Type 1 Diabetes.Perkins BA, Bebu I, de Boer IH, Molitch M, Tamborlane W, Lorenzi G, Herman W, White NH, Pop-Busui R, Paterson AD, Orchard T, Cowie C, Lachin JM. Risk Factors for Kidney Disease in Type 1 Diabetes. Diabetes Care 2019, 42: 883-890. PMID: 30833370, PMCID: PMC6489116, DOI: 10.2337/dc18-2062.
• International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, Alexander CM, Battelino T, Ampudia-Blasco FJ, Bode BW, Cariou B, Close KL, Dandona P, Dutta S, Ferrannini E, Fourlanos S, Grunberger G, Heller SR, Henry RR, Kurian MJ, Kushner JA, Oron T, Parkin CG, Pieber TR, Rodbard HW, Schatz D, Skyler JS, Tamborlane WV, Yokote K, Phillip M. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors. Diabetes Care 2019, 42: 1147-1154. PMID: 30728224, PMCID: PMC6973545, DOI: 10.2337/dc18-2316.
• IMPACT OF SWITCHING YOUTH WITH DIABETES TO INSULIN DEGLUDEC IN CLINICAL PRACTICE.Elahi S, Patel AD, Guandalini C, Steffen A, Sherr J, Tamborlane WV, Van Name MA. IMPACT OF SWITCHING YOUTH WITH DIABETES TO INSULIN DEGLUDEC IN CLINICAL PRACTICE. Endocrine Practice : Official Journal Of The American College Of Endocrinology And The American Association Of Clinical Endocrinologists 2019, 25: 226-229. PMID: 30913005, DOI: 10.4158/EP-2018-0417.
• Liraglutide in Children and Adolescents with Type 2 Diabetes.Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T. Liraglutide in Children and Adolescents with Type 2 Diabetes. The New England Journal Of Medicine 2019, 381: 637-646. PMID: 31034184, DOI: 10.1056/NEJMoa1903822.
• Effect of Injection Site Cooling and Warming on Insulin Glargine Pharmacokinetics and Pharmacodynamics.Bitton G, Rom V, Hadelsberg U, Raz I, Cengiz E, Weinzimer S, Tamborlane WV. Effect of Injection Site Cooling and Warming on Insulin Glargine Pharmacokinetics and Pharmacodynamics. Journal Of Diabetes Science And Technology 2019, 13: 1123-1128. PMID: 31067999, PMCID: PMC6835184, DOI: 10.1177/1932296819842151.
• Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study.Shah VN, DuBose SN, Li Z, Beck RW, Peters AL, Weinstock RS, Kruger D, Tansey M, Sparling D, Woerner S, Vendrame F, Bergenstal R, Tamborlane WV, Watson SE, Sherr J. Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study. The Journal Of Clinical Endocrinology And Metabolism 2019, 104: 4356-4364. PMID: 31127824, PMCID: PMC7296129, DOI: 10.1210/jc.2018-02763.
• Screening eye exams in youth with type 1 diabetes under 18 years of age: Once may be enough?Gubitosi-Klug RA, Bebu I, White NH, Malone J, Miller R, Lorenzi GM, Hainsworth DP, Trapani VR, Lachin JM, Tamborlane WV. Screening eye exams in youth with type 1 diabetes under 18 years of age: Once may be enough? Pediatric Diabetes 2019, 20: 743-749. PMID: 31206973, PMCID: PMC7217664, DOI: 10.1111/pedi.12877.
• Glucose management for rewards: A randomized trial to improve glucose monitoring and associated self-management behaviors in adolescents with type 1 diabetes.Wagner JA, Petry NM, Weyman K, Tichy E, Cengiz E, Zajac K, Tamborlane WV. Glucose management for rewards: A randomized trial to improve glucose monitoring and associated self-management behaviors in adolescents with type 1 diabetes. Pediatric Diabetes 2019, 20: 997-1006. PMID: 31271239, PMCID: PMC6786915, DOI: 10.1111/pedi.12889.
• Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic network.McGill JB, Wu M, Pop-Busui R, Mizokami-Stout K, Tamborlane WV, Aleppo G, Gubitosi-Klug RA, Haller MJ, Willi SM, Foster NC, Zimmerman C, Libman I, Polsky S, Rickels MR. Biologic and social factors predict incident kidney disease in type 1 diabetes: Results from the T1D exchange clinic network. Journal Of Diabetes And Its Complications 2019, 33: 107400. PMID: 31279735, DOI: 10.1016/j.jdiacomp.2019.06.005.
• Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes.Hilliard ME, Levy W, Anderson BJ, Whitehouse AL, Commissariat PV, Harrington KR, Laffel LM, Miller KM, Van Name M, Tamborlane WV, DeSalvo DJ, DiMeglio LA. Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes. Diabetes Technology & Therapeutics 2019, 21: 493-498. PMID: 31287721, PMCID: PMC6708264, DOI: 10.1089/dia.2019.0142.
• Liraglutide in Children and Teens with Type 2 Diabetes. Reply.Tamborlane WV, Fainberg U, Barrett T. Liraglutide in Children and Teens with Type 2 Diabetes. Reply. The New England Journal Of Medicine 2019, 381: 1787. PMID: 31665592, DOI: 10.1056/NEJMc1912498.
• Executive task-based brain function in children with type 1 diabetes: An observational study.Foland-Ross LC, Buckingam B, Mauras N, Arbelaez AM, Tamborlane WV, Tsalikian E, Cato A, Tong G, Englert K, Mazaika PK, Reiss AL. Executive task-based brain function in children with type 1 diabetes: An observational study. PLoS Medicine 2019, 16: e1002979. PMID: 31815939, PMCID: PMC6901178, DOI: 10.1371/journal.pmed.1002979.
• Greater parental comfort with lower glucose targets in young children with Type 1 diabetes using continuous glucose monitoring.Van Name MA, Miller KM, Commissariat PV, Whitehouse AL, Harrington KR, Anderson BJ, Mantravadi MG, Levy W, DeSalvo DJ, Tamborlane WV, Hilliard ME, Laffel LM, DiMeglio LA. Greater parental comfort with lower glucose targets in young children with Type 1 diabetes using continuous glucose monitoring. Diabetic Medicine : A Journal Of The British Diabetic Association 2019, 36: 1508-1510. PMID: 31295359, PMCID: PMC7027357, DOI: 10.1111/dme.14074.
• "I'm essentially his pancreas": Parent perceptions of diabetes burden and opportunities to reduce burden in the care of children <8 years old with type 1 diabetes.Commissariat PV, Harrington KR, Whitehouse AL, Miller KM, Hilliard ME, Van Name M, DeSalvo DJ, Tamborlane WV, Anderson BJ, DiMeglio LA, Laffel LM. "I'm essentially his pancreas": Parent perceptions of diabetes burden and opportunities to reduce burden in the care of children <8 years old with type 1 diabetes. Pediatric Diabetes 2020, 21: 377-383. PMID: 31808586, PMCID: PMC7830825, DOI: 10.1111/pedi.12956.
• Transforming Performance of Clinical Trials in Pediatric Type 2 Diabetes: A Consortium Model.Van Name M, Klingensmith G, Nelson B, Wintergerst K, Mitchell J, Norris K, Tamborlane W. Transforming Performance of Clinical Trials in Pediatric Type 2 Diabetes: A Consortium Model. Diabetes Technology & Therapeutics 2020, 22: 330-336. PMID: 31859529, PMCID: PMC7869879, DOI: 10.1089/dia.2019.0448.
• Effect of Exercise and Meals on Continuous Glucose Monitor Data in Healthy Individuals Without Diabetes.DuBose SN, Li Z, Sherr JL, Beck RW, Tamborlane WV, Shah VN. Effect of Exercise and Meals on Continuous Glucose Monitor Data in Healthy Individuals Without Diabetes. Journal Of Diabetes Science And Technology 2021, 15: 593-599. PMID: 32064911, PMCID: PMC8120054, DOI: 10.1177/1932296820905904.
• Sources and Valence of Information Impacting Parents' Decisions to Use Diabetes Technologies in Young Children <8 Years Old with Type 1 Diabetes.Commissariat P, Whitehouse A, Hilliard M, Miller KM, Harrington KR, Levy W, DeSalvo DJ, Van Name M, Anderson B, Tamborlane W, DiMeglio LA, Laffel LM. Sources and Valence of Information Impacting Parents' Decisions to Use Diabetes Technologies in Young Children <8 Years Old with Type 1 Diabetes. Diabetes Technology & Therapeutics 2020, 22: 697-700. PMID: 32077755, PMCID: PMC7718841, DOI: 10.1089/dia.2019.0497.
• Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6-17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial.Danne T, Tamborlane WV, Malievsky OA, Franco DR, Kawamura T, Demissie M, Niemoeller E, Goyeau H, Wardecki M, Battelino T. Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6-17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial. Diabetes Care 2020, 43: 1512-1519. PMID: 32430458, PMCID: PMC7305011, DOI: 10.2337/dc19-1926.
• Alcohol Use and Clinical Outcomes in Adults in the Type 1 Diabetes Exchange.Alessi SM, Foster NC, Rash CJ, Van Name MA, Tamborlane WV, Cengiz E, Polsky S, Wagner J. Alcohol Use and Clinical Outcomes in Adults in the Type 1 Diabetes Exchange. Canadian Journal Of Diabetes 2020, 44: 501-506. PMID: 32792103, DOI: 10.1016/j.jcjd.2020.06.005.
• Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.Hainsworth DP, Gao X, Bebu I, Das A, Olmos de Koo L, Barkmeier AJ, Tamborlane W, Lachin JM, Aiello LP. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Ophthalmology 2021, 128: 554-560. PMID: 32941962, PMCID: PMC7956062, DOI: 10.1016/j.ophtha.2020.09.014.
• Erratum. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2017;40:1010-1016.Gubitosi-Klug RA, Braffett BH, White NH, Sherwin RS, Service FJ, Lachin JM, Tamborlane WV. Erratum. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2017;40:1010-1016. Diabetes Care 2021, 44: 298. PMID: 33158952, PMCID: PMC7783934, DOI: 10.2337/dc21-er01a.
• A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Finger-stick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes.DiMeglio LA, Kanapka LG, DeSalvo DJ, Hilliard ME, Laffel LM, Tamborlane WV, Van Name MA, Woerner S, Adi S, Albanese-O'Neill A, Alonso GT, Anderson BJ, Corathers SD, Fegan-Bohm K, Forlenza GP, Gandica RG, Goland RS, Haller MJ, Hanono A, Harrington KR, Ismail HM, Jolivette HA, Kelley JC, Kingery S, MacLeish SA, Majidi S, Miller KM, Minnock PP, Nathan BM, Sheanon NM, Simmons JH, Sunni M, Wadwa RP, Watson SE, Weyman K, Williams KM, Willi SM, Wintergerst KA, Wood J. A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Finger-stick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes. Diabetes Care 2020 PMID: 33334807, DOI: 10.2337/dc20-1060.
• An Effective Diabetic Ketoacidosis Prevention Intervention in Children With Type 1 Diabetes.Vitale RJ, Card CE, Lichtman JH, Weyman K, Michaud C, Sikes K, Tamborlane WV, Weinzimer SA. An Effective Diabetic Ketoacidosis Prevention Intervention in Children With Type 1 Diabetes. SAGE Open Nursing 2018, 4: 2377960818804742. PMID: 33415207, PMCID: PMC7774356, DOI: 10.1177/2377960818804742.
• Impact of Type 1 Diabetes in the Developing Brain in Children: A Longitudinal Study.Mauras N, Buckingham B, White NH, Tsalikian E, Weinzimer SA, Jo B, Cato A, Fox LA, Aye T, Arbelaez AM, Hershey T, Tansey M, Tamborlane W, Foland-Ross LC, Shen H, Englert K, Mazaika P, Marzelli M, Reiss AL. Impact of Type 1 Diabetes in the Developing Brain in Children: A Longitudinal Study. Diabetes Care 2021, 44: 983-992. PMID: 33568403, PMCID: PMC7985430, DOI: 10.2337/dc20-2125.
• Children and adolescents with type 1 and type 2 diabetes mellitus in the Pediatric Diabetes Consortium Registries: comparing clinical characteristics and glycaemic control.Van Name MA, Cheng P, Gal RL, Kollman C, Lynch J, Nelson B, Tamborlane WV. Children and adolescents with type 1 and type 2 diabetes mellitus in the Pediatric Diabetes Consortium Registries: comparing clinical characteristics and glycaemic control. Diabetic Medicine : A Journal Of The British Diabetic Association 2020, 37: 863-867. PMID: 31943374, DOI: 10.1111/dme.14233.
• Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study.DiMeglio LA, Kanapka LG, DeSalvo DJ, Anderson BJ, Harrington KR, Hilliard ME, Laffel LM, Tamborlane WV, Van Name MA, Wadwa RP, Willi SM, Woerner S, Wong JC, Miller KM. Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study. Diabetic Medicine : A Journal Of The British Diabetic Association 2020, 37: 1308-1315. PMID: 32096282, DOI: 10.1111/dme.14276.
• Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes.Gubitosi-Klug R, Gao X, Pop-Busui R, de Boer IH, White N, Aiello LP, Miller R, Palmer J, Tamborlane W, Wallia A, Kosiborod M, Lachin JM, Bebu I. Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes. Diabetes Care 2021, 44: 1499-1505. PMID: 33980605, PMCID: PMC8323173, DOI: 10.2337/dc20-3104.
• A Pilot Study of Youth With Type 1 Diabetes Initiating Use of a Hybrid Closed-Loop System While Receiving a Behavioral Economics Intervention.Nally LM, Wagner J, Sherr J, Tichy E, Weyman K, Ginley MK, Zajac K, Desousa M, Shabanova V, Petry NM, Tamborlane WV, Van Name M. A Pilot Study of Youth With Type 1 Diabetes Initiating Use of a Hybrid Closed-Loop System While Receiving a Behavioral Economics Intervention. Endocrine Practice : Official Journal Of The American College Of Endocrinology And The American Association Of Clinical Endocrinologists 2021, 27: 545-551. PMID: 34120699, PMCID: PMC8206518, DOI: 10.1016/j.eprac.2020.11.017.
• Racial and Ethnic Disparities in Comorbidities in Youth With Type 2 Diabetes in the Pediatric Diabetes Consortium (PDC).Bacha F, Cheng P, Gal RL, Beaulieu LC, Kollman C, Adolph A, Shoemaker AH, Wolf R, Klingensmith GJ, Tamborlane WV. Racial and Ethnic Disparities in Comorbidities in Youth With Type 2 Diabetes in the Pediatric Diabetes Consortium (PDC). Diabetes Care 2021 PMID: 34475033, DOI: 10.2337/dc21-0143.
• Case Report: Managing Pregnancy With Type 1 Diabetes Using a Do-It-Yourself Artificial Pancreas System.Waikar AR, Arora T, Haynes M, Tamborlane WV, Nally LM. Case Report: Managing Pregnancy With Type 1 Diabetes Using a Do-It-Yourself Artificial Pancreas System. Clinical Diabetes : A Publication Of The American Diabetes Association 2021, 39: 441-444. PMID: 34866788, PMCID: PMC8603326, DOI: 10.2337/cd20-0128.
• Corrigendum to: Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline.Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, Wolpert H. Corrigendum to: Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline. The Journal Of Clinical Endocrinology And Metabolism 2021 PMID: 34878114, DOI: 10.1210/clinem/dgab251.
• Late Endocrine Effects after Stem Cell Transplant in a Young Girl with Griscelli Syndrome.Mencher SR, Tamborlane WV, Patel AD. Late Endocrine Effects after Stem Cell Transplant in a Young Girl with Griscelli Syndrome. Case Reports In Pediatrics 2021, 2021: 9981306. PMID: 34987878, PMCID: PMC8723881, DOI: 10.1155/2021/9981306.
• Tobacco use patterns and clinical outcomes in the T1D exchange.Rash CJ, Alessi SM, Foster N, Tamborlane W, Van Name MA, Wagner JA. Tobacco use patterns and clinical outcomes in the T1D exchange. Journal Of Diabetes And Its Complications 2022, 36: 108128. PMID: 35058139, PMCID: PMC8881793, DOI: 10.1016/j.jdiacomp.2022.108128.
• Continuous Glucose Monitoring in Adults With Type 1 Diabetes With 35 Years Duration From the DCCT/EDIC Study.Gubitosi-Klug RA, Braffett BH, Bebu I, Johnson ML, Farrell K, Kenny D, Trapani VR, Meadema-Mayer L, Soliman EZ, Pop-Busui R, Lachin JM, Bergenstal RM, Tamborlane WV. Continuous Glucose Monitoring in Adults With Type 1 Diabetes With 35 Years Duration From the DCCT/EDIC Study. Diabetes Care 2022, 45: 659-665. PMID: 35076697, PMCID: PMC8918229, DOI: 10.2337/dc21-0629.
• Youth with type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: A Pediatric Diabetes Consortium study.Wolf RM, Cheng P, Gal RL, Beaulieu LC, Kollman C, Isganaitis E, Magge S, Mastrandrea LD, Klingensmith GJ, Tamborlane W, Van Name M. Youth with type 2 diabetes have a high rate of treatment failure after discontinuation of insulin: A Pediatric Diabetes Consortium study. Pediatric Diabetes 2022, 23: 439-446. PMID: 35138021, DOI: 10.1111/pedi.13325.
• Long-term Continuous Glucose Monitor Use in Very Young Children With Type 1 Diabetes: One-Year Results From the SENCE Study.Van Name MA, Kanapka LG, DiMeglio LA, Miller KM, Albanese-O'Neill A, Commissariat P, Corathers SD, Harrington KR, Hilliard ME, Anderson BJ, Kelley JC, Laffel LM, MacLeish SA, Nathan BM, Tamborlane WV, Wadwa RP, Willi SM, Williams KM, Wintergerst KA, Woerner S, Wong JC, DeSalvo DJ. Long-term Continuous Glucose Monitor Use in Very Young Children With Type 1 Diabetes: One-Year Results From the SENCE Study. Journal Of Diabetes Science And Technology 2022, 19322968221084667. PMID: 35343269, DOI: 10.1177/19322968221084667.
• Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study.Tamborlane WV, Laffel LM, Shehadeh N, Isganaitis E, Van Name M, Ratnayake J, Karlsson C, Norjavaara E. Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study. The Lancet. Diabetes & Endocrinology 2022, 10: 341-350. PMID: 35378069, DOI: 10.1016/S2213-8587(22)00052-3.
• SGLT2i Improves Glycemic Control in Patients With Congenital Severe Insulin Resistance.Galderisi A, Tamborlane W, Taylor SI, Attia N, Moretti C, Barbetti F. SGLT2i Improves Glycemic Control in Patients With Congenital Severe Insulin Resistance. Pediatrics 2022 PMID: 35652305, DOI: 10.1542/peds.2021-055671.
• Once-Weekly Exenatide in Youth With Type 2 Diabetes.Tamborlane WV, Bishai R, Geller D, Shehadeh N, Al-Abdulrazzaq D, Vazquez EM, Karoly E, Troja T, Doehring O, Carter D, Monyak J, Sjöström CD. Once-Weekly Exenatide in Youth With Type 2 Diabetes. Diabetes Care 2022 PMID: 35679098, DOI: 10.2337/dc21-2275.